WO2023052506A1 - Membranes - Google Patents
Membranes Download PDFInfo
- Publication number
- WO2023052506A1 WO2023052506A1 PCT/EP2022/077120 EP2022077120W WO2023052506A1 WO 2023052506 A1 WO2023052506 A1 WO 2023052506A1 EP 2022077120 W EP2022077120 W EP 2022077120W WO 2023052506 A1 WO2023052506 A1 WO 2023052506A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- polymer
- curable composition
- layer
- charge
- curable
- Prior art date
Links
- 239000012528 membrane Substances 0.000 title claims abstract description 97
- 238000004519 manufacturing process Methods 0.000 claims abstract description 9
- 229920000642 polymer Polymers 0.000 claims description 255
- 239000000203 mixture Substances 0.000 claims description 186
- 125000003010 ionic group Chemical group 0.000 claims description 100
- 150000001875 compounds Chemical class 0.000 claims description 65
- 239000011148 porous material Substances 0.000 claims description 55
- 238000000034 method Methods 0.000 claims description 40
- 230000008569 process Effects 0.000 claims description 33
- 239000002904 solvent Substances 0.000 claims description 25
- 125000000129 anionic group Chemical group 0.000 claims description 21
- 125000002091 cationic group Chemical group 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 17
- 239000003054 catalyst Substances 0.000 claims description 13
- 239000011888 foil Substances 0.000 claims description 13
- 239000003999 initiator Substances 0.000 claims description 13
- 238000005191 phase separation Methods 0.000 claims description 11
- 150000003839 salts Chemical class 0.000 claims description 6
- 238000000909 electrodialysis Methods 0.000 claims description 3
- 229910052751 metal Inorganic materials 0.000 claims description 3
- 239000002184 metal Substances 0.000 claims description 3
- 229910044991 metal oxide Inorganic materials 0.000 claims description 3
- 150000004706 metal oxides Chemical class 0.000 claims description 3
- 150000002902 organometallic compounds Chemical class 0.000 claims description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 3
- 102000004169 proteins and genes Human genes 0.000 claims description 3
- 239000012298 atmosphere Substances 0.000 claims description 2
- 239000003546 flue gas Substances 0.000 claims description 2
- 150000007522 mineralic acids Chemical class 0.000 claims description 2
- 229920001542 oligosaccharide Polymers 0.000 claims description 2
- 150000002482 oligosaccharides Chemical class 0.000 claims description 2
- 150000007524 organic acids Chemical class 0.000 claims description 2
- 238000011084 recovery Methods 0.000 claims description 2
- 239000002585 base Substances 0.000 description 34
- -1 hydroxide ions Chemical class 0.000 description 25
- 238000001723 curing Methods 0.000 description 22
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 18
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 12
- 125000000217 alkyl group Chemical group 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 9
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 9
- 150000003254 radicals Chemical class 0.000 description 9
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 125000003118 aryl group Chemical group 0.000 description 6
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 6
- 238000000157 electrochemical-induced impedance spectroscopy Methods 0.000 description 6
- GNOIPBMMFNIUFM-UHFFFAOYSA-N hexamethylphosphoric triamide Chemical compound CN(C)P(=O)(N(C)C)N(C)C GNOIPBMMFNIUFM-UHFFFAOYSA-N 0.000 description 6
- 150000002500 ions Chemical class 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 238000001308 synthesis method Methods 0.000 description 6
- 239000003990 capacitor Substances 0.000 description 5
- 238000005341 cation exchange Methods 0.000 description 5
- 239000002131 composite material Substances 0.000 description 5
- 239000003792 electrolyte Substances 0.000 description 5
- 125000005647 linker group Chemical group 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 238000011282 treatment Methods 0.000 description 5
- JWUJQDFVADABEY-UHFFFAOYSA-N 2-methyltetrahydrofuran Chemical compound CC1CCCO1 JWUJQDFVADABEY-UHFFFAOYSA-N 0.000 description 4
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 230000002378 acidificating effect Effects 0.000 description 4
- 125000002947 alkylene group Chemical group 0.000 description 4
- 229920006318 anionic polymer Polymers 0.000 description 4
- 229920006317 cationic polymer Polymers 0.000 description 4
- 150000001768 cations Chemical class 0.000 description 4
- 238000010494 dissociation reaction Methods 0.000 description 4
- 208000018459 dissociative disease Diseases 0.000 description 4
- SKTCDJAMAYNROS-UHFFFAOYSA-N methoxycyclopentane Chemical compound COC1CCCC1 SKTCDJAMAYNROS-UHFFFAOYSA-N 0.000 description 4
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical compound O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 4
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 4
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 3
- CYSGHNMQYZDMIA-UHFFFAOYSA-N 1,3-Dimethyl-2-imidazolidinon Chemical compound CN1CCN(C)C1=O CYSGHNMQYZDMIA-UHFFFAOYSA-N 0.000 description 3
- WNXJIVFYUVYPPR-UHFFFAOYSA-N 1,3-dioxolane Chemical compound C1COCO1 WNXJIVFYUVYPPR-UHFFFAOYSA-N 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 3
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 239000004743 Polypropylene Substances 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 3
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000005349 anion exchange Methods 0.000 description 3
- 239000003011 anion exchange membrane Substances 0.000 description 3
- 150000001450 anions Chemical class 0.000 description 3
- 150000008365 aromatic ketones Chemical class 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- LWMFAFLIWMPZSX-UHFFFAOYSA-N bis[2-(4,5-dihydro-1h-imidazol-2-yl)propan-2-yl]diazene Chemical compound N=1CCNC=1C(C)(C)N=NC(C)(C)C1=NCCN1 LWMFAFLIWMPZSX-UHFFFAOYSA-N 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 3
- 238000010894 electron beam technology Methods 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 239000003014 ion exchange membrane Substances 0.000 description 3
- 239000003456 ion exchange resin Substances 0.000 description 3
- 229920003303 ion-exchange polymer Polymers 0.000 description 3
- SFLRURCEBYIKSS-UHFFFAOYSA-N n-butyl-2-[[1-(butylamino)-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound CCCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCCC SFLRURCEBYIKSS-UHFFFAOYSA-N 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- FVSKHRXBFJPNKK-UHFFFAOYSA-N propionitrile Chemical compound CCC#N FVSKHRXBFJPNKK-UHFFFAOYSA-N 0.000 description 3
- 238000005215 recombination Methods 0.000 description 3
- 230000006798 recombination Effects 0.000 description 3
- 235000011149 sulphuric acid Nutrition 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 2
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 2
- JTXMVXSTHSMVQF-UHFFFAOYSA-N 2-acetyloxyethyl acetate Chemical compound CC(=O)OCCOC(C)=O JTXMVXSTHSMVQF-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 101100058598 Arabidopsis thaliana BPM1 gene Proteins 0.000 description 2
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000004952 Polyamide Substances 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920002873 Polyethylenimine Polymers 0.000 description 2
- 239000004734 Polyphenylene sulfide Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical compound N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 239000005456 alcohol based solvent Substances 0.000 description 2
- 125000004450 alkenylene group Chemical group 0.000 description 2
- 150000001449 anionic compounds Chemical class 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 125000000732 arylene group Chemical group 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical class C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- RWCCWEUUXYIKHB-UHFFFAOYSA-N benzophenone Chemical group C=1C=CC=CC=1C(=O)C1=CC=CC=C1 RWCCWEUUXYIKHB-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 229940098773 bovine serum albumin Drugs 0.000 description 2
- 229930188620 butyrolactone Natural products 0.000 description 2
- 229910002092 carbon dioxide Inorganic materials 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- VFLDPWHFBUODDF-FCXRPNKRSA-N curcumin Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)CC(=O)\C=C\C=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-FCXRPNKRSA-N 0.000 description 2
- YEJRWHAVMIAJKC-UHFFFAOYSA-N gamma-butyrolactone Natural products O=C1CCCO1 YEJRWHAVMIAJKC-UHFFFAOYSA-N 0.000 description 2
- 229910052736 halogen Inorganic materials 0.000 description 2
- GPRLSGONYQIRFK-UHFFFAOYSA-N hydron Chemical compound [H+] GPRLSGONYQIRFK-UHFFFAOYSA-N 0.000 description 2
- 239000012442 inert solvent Substances 0.000 description 2
- 229910001412 inorganic anion Inorganic materials 0.000 description 2
- 230000037427 ion transport Effects 0.000 description 2
- 229960004592 isopropanol Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 239000002121 nanofiber Substances 0.000 description 2
- 150000002891 organic anions Chemical class 0.000 description 2
- 238000000016 photochemical curing Methods 0.000 description 2
- 229920002239 polyacrylonitrile Polymers 0.000 description 2
- 229920002647 polyamide Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 229920000069 polyphenylene sulfide Polymers 0.000 description 2
- 229920001155 polypropylene Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000001453 quaternary ammonium group Chemical group 0.000 description 2
- LISFMEBWQUVKPJ-UHFFFAOYSA-N quinolin-2-ol Chemical compound C1=CC=C2NC(=O)C=CC2=C1 LISFMEBWQUVKPJ-UHFFFAOYSA-N 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 229920002994 synthetic fiber Polymers 0.000 description 2
- 238000001029 thermal curing Methods 0.000 description 2
- YRHRIQCWCFGUEQ-UHFFFAOYSA-N thioxanthen-9-one Chemical group C1=CC=C2C(=O)C3=CC=CC=C3SC2=C1 YRHRIQCWCFGUEQ-UHFFFAOYSA-N 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
- FEPMHVLSLDOMQC-UHFFFAOYSA-N virginiamycin-S1 Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC=CC=2)N(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O FEPMHVLSLDOMQC-UHFFFAOYSA-N 0.000 description 2
- JNELGWHKGNBSMD-UHFFFAOYSA-N xanthone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3OC2=C1 JNELGWHKGNBSMD-UHFFFAOYSA-N 0.000 description 2
- TXUICONDJPYNPY-UHFFFAOYSA-N (1,10,13-trimethyl-3-oxo-4,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl) heptanoate Chemical compound C1CC2CC(=O)C=C(C)C2(C)C2C1C1CCC(OC(=O)CCCCCC)C1(C)CC2 TXUICONDJPYNPY-UHFFFAOYSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- VNQXSTWCDUXYEZ-UHFFFAOYSA-N 1,7,7-trimethylbicyclo[2.2.1]heptane-2,3-dione Chemical compound C1CC2(C)C(=O)C(=O)C1C2(C)C VNQXSTWCDUXYEZ-UHFFFAOYSA-N 0.000 description 1
- WJFKNYWRSNBZNX-UHFFFAOYSA-N 10H-phenothiazine Chemical compound C1=CC=C2NC3=CC=CC=C3SC2=C1 WJFKNYWRSNBZNX-UHFFFAOYSA-N 0.000 description 1
- TZMSYXZUNZXBOL-UHFFFAOYSA-N 10H-phenoxazine Chemical compound C1=CC=C2NC3=CC=CC=C3OC2=C1 TZMSYXZUNZXBOL-UHFFFAOYSA-N 0.000 description 1
- VEPOHXYIFQMVHW-XOZOLZJESA-N 2,3-dihydroxybutanedioic acid (2S,3S)-3,4-dimethyl-2-phenylmorpholine Chemical compound OC(C(O)C(O)=O)C(O)=O.C[C@H]1[C@@H](OCCN1C)c1ccccc1 VEPOHXYIFQMVHW-XOZOLZJESA-N 0.000 description 1
- AVTLBBWTUPQRAY-UHFFFAOYSA-N 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile Chemical compound CCC(C)(C#N)N=NC(C)(CC)C#N AVTLBBWTUPQRAY-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- OFGGQKXKKPUVOV-UHFFFAOYSA-N 2-[(1-imino-2-methyl-1-pyrrolidin-1-ylbutan-2-yl)diazenyl]-2-methyl-1-pyrrolidin-1-ylbutan-1-imine;dihydrochloride Chemical compound Cl.Cl.C1CCCN1C(=N)C(C)(CC)N=NC(C)(CC)C(=N)N1CCCC1 OFGGQKXKKPUVOV-UHFFFAOYSA-N 0.000 description 1
- PFHOSZAOXCYAGJ-UHFFFAOYSA-N 2-[(2-cyano-4-methoxy-4-methylpentan-2-yl)diazenyl]-4-methoxy-2,4-dimethylpentanenitrile Chemical compound COC(C)(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)(C)OC PFHOSZAOXCYAGJ-UHFFFAOYSA-N 0.000 description 1
- WYGWHHGCAGTUCH-UHFFFAOYSA-N 2-[(2-cyano-4-methylpentan-2-yl)diazenyl]-2,4-dimethylpentanenitrile Chemical compound CC(C)CC(C)(C#N)N=NC(C)(C#N)CC(C)C WYGWHHGCAGTUCH-UHFFFAOYSA-N 0.000 description 1
- FLKBKUFGKQPPRY-UHFFFAOYSA-N 2-[2-[2-[2-[1-(2-hydroxyethyl)-4,5-dihydroimidazol-2-yl]propan-2-yldiazenyl]propan-2-yl]-4,5-dihydroimidazol-1-yl]ethanol;dihydrochloride Chemical compound Cl.Cl.N=1CCN(CCO)C=1C(C)(C)N=NC(C)(C)C1=NCCN1CCO FLKBKUFGKQPPRY-UHFFFAOYSA-N 0.000 description 1
- CKSAKVMRQYOFBC-UHFFFAOYSA-N 2-cyanopropan-2-yliminourea Chemical compound N#CC(C)(C)N=NC(N)=O CKSAKVMRQYOFBC-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- GOLORTLGFDVFDW-UHFFFAOYSA-N 3-(1h-benzimidazol-2-yl)-7-(diethylamino)chromen-2-one Chemical compound C1=CC=C2NC(C3=CC4=CC=C(C=C4OC3=O)N(CC)CC)=NC2=C1 GOLORTLGFDVFDW-UHFFFAOYSA-N 0.000 description 1
- BVYRHLPUAHNHKR-UHFFFAOYSA-N 3-[[1-amino-2-[[1-amino-1-(2-carboxyethylimino)-2-methylpropan-2-yl]diazenyl]-2-methylpropylidene]amino]propanoic acid;hydrate Chemical compound O.OC(=O)CCNC(=N)C(C)(C)N=NC(C)(C)C(=N)NCCC(O)=O BVYRHLPUAHNHKR-UHFFFAOYSA-N 0.000 description 1
- VFXXTYGQYWRHJP-UHFFFAOYSA-N 4,4'-azobis(4-cyanopentanoic acid) Chemical compound OC(=O)CCC(C)(C#N)N=NC(C)(CCC(O)=O)C#N VFXXTYGQYWRHJP-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- PQJUJGAVDBINPI-UHFFFAOYSA-N 9H-thioxanthene Chemical compound C1=CC=C2CC3=CC=CC=C3SC2=C1 PQJUJGAVDBINPI-UHFFFAOYSA-N 0.000 description 1
- GJCOSYZMQJWQCA-UHFFFAOYSA-N 9H-xanthene Chemical compound C1=CC=C2CC3=CC=CC=C3OC2=C1 GJCOSYZMQJWQCA-UHFFFAOYSA-N 0.000 description 1
- OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 1
- GDALETGZDYOOGB-UHFFFAOYSA-N Acridone Natural products C1=C(O)C=C2N(C)C3=CC=CC=C3C(=O)C2=C1O GDALETGZDYOOGB-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical group NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- 101100439208 Caenorhabditis elegans cex-1 gene Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229920001410 Microfiber Polymers 0.000 description 1
- 238000010547 Norrish type II reaction Methods 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000004696 Poly ether ether ketone Substances 0.000 description 1
- 239000004962 Polyamide-imide Substances 0.000 description 1
- 239000004695 Polyether sulfone Substances 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- LXEKPEMOWBOYRF-UHFFFAOYSA-N [2-[(1-azaniumyl-1-imino-2-methylpropan-2-yl)diazenyl]-2-methylpropanimidoyl]azanium;dichloride Chemical compound Cl.Cl.NC(=N)C(C)(C)N=NC(C)(C)C(N)=N LXEKPEMOWBOYRF-UHFFFAOYSA-N 0.000 description 1
- MAHXNHGMCSURBE-UHFFFAOYSA-N [4-[2-(dimethylamino)benzoyl]phenyl]-[2-(dimethylamino)phenyl]methanone Chemical compound CN(C)C1=CC=CC=C1C(=O)C1=CC=C(C(=O)C=2C(=CC=CC=2)N(C)C)C=C1 MAHXNHGMCSURBE-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000002479 acid--base titration Methods 0.000 description 1
- FZEYVTFCMJSGMP-UHFFFAOYSA-N acridone Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3NC2=C1 FZEYVTFCMJSGMP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M acrylate group Chemical group C(C=C)(=O)[O-] NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 238000007754 air knife coating Methods 0.000 description 1
- 150000007933 aliphatic carboxylic acids Chemical class 0.000 description 1
- 229920003232 aliphatic polyester Polymers 0.000 description 1
- 229910001413 alkali metal ion Inorganic materials 0.000 description 1
- 125000004419 alkynylene group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 235000010208 anthocyanin Nutrition 0.000 description 1
- 239000004410 anthocyanin Substances 0.000 description 1
- 229930002877 anthocyanin Natural products 0.000 description 1
- 150000004636 anthocyanins Chemical class 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 125000005235 azinium group Chemical group 0.000 description 1
- 125000000751 azo group Chemical group [*]N=N[*] 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- ZYGHJZDHTFUPRJ-UHFFFAOYSA-N benzo-alpha-pyrone Natural products C1=CC=C2OC(=O)C=CC2=C1 ZYGHJZDHTFUPRJ-UHFFFAOYSA-N 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 150000008366 benzophenones Chemical class 0.000 description 1
- 229930006711 bornane-2,3-dione Natural products 0.000 description 1
- 150000001642 boronic acid derivatives Chemical class 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 150000001767 cationic compounds Chemical class 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 238000003851 corona treatment Methods 0.000 description 1
- 235000001671 coumarin Nutrition 0.000 description 1
- 150000004775 coumarins Chemical class 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 235000012754 curcumin Nutrition 0.000 description 1
- 239000004148 curcumin Substances 0.000 description 1
- 229940109262 curcumin Drugs 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- VBWIZSYFQSOUFQ-UHFFFAOYSA-N cyclohexanecarbonitrile Chemical compound N#CC1CCCCC1 VBWIZSYFQSOUFQ-UHFFFAOYSA-N 0.000 description 1
- VFLDPWHFBUODDF-UHFFFAOYSA-N diferuloylmethane Natural products C1=C(O)C(OC)=CC(C=CC(=O)CC(=O)C=CC=2C=C(OC)C(O)=CC=2)=C1 VFLDPWHFBUODDF-UHFFFAOYSA-N 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- OVTCUIZCVUGJHS-UHFFFAOYSA-N dipyrrin Chemical compound C=1C=CNC=1C=C1C=CC=N1 OVTCUIZCVUGJHS-UHFFFAOYSA-N 0.000 description 1
- 208000028659 discharge Diseases 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005868 electrolysis reaction Methods 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000004210 ether based solvent Substances 0.000 description 1
- 239000004744 fabric Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002212 flavone derivatives Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- YLQWCDOCJODRMT-UHFFFAOYSA-N fluoren-9-one Chemical compound C1=CC=C2C(=O)C3=CC=CC=C3C2=C1 YLQWCDOCJODRMT-UHFFFAOYSA-N 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910001411 inorganic cation Inorganic materials 0.000 description 1
- 229910001410 inorganic ion Inorganic materials 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- 239000005453 ketone based solvent Substances 0.000 description 1
- QDLAGTHXVHQKRE-UHFFFAOYSA-N lichenxanthone Natural products COC1=CC(O)=C2C(=O)C3=C(C)C=C(OC)C=C3OC2=C1 QDLAGTHXVHQKRE-UHFFFAOYSA-N 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- FPYJFEHAWHCUMM-UHFFFAOYSA-N maleic anhydride Chemical compound O=C1OC(=O)C=C1 FPYJFEHAWHCUMM-UHFFFAOYSA-N 0.000 description 1
- 238000013507 mapping Methods 0.000 description 1
- ZQMHJBXHRFJKOT-UHFFFAOYSA-N methyl 2-[(1-methoxy-2-methyl-1-oxopropan-2-yl)diazenyl]-2-methylpropanoate Chemical compound COC(=O)C(C)(C)N=NC(C)(C)C(=O)OC ZQMHJBXHRFJKOT-UHFFFAOYSA-N 0.000 description 1
- 239000003658 microfiber Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- WVFLGSMUPMVNTQ-UHFFFAOYSA-N n-(2-hydroxyethyl)-2-[[1-(2-hydroxyethylamino)-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCO WVFLGSMUPMVNTQ-UHFFFAOYSA-N 0.000 description 1
- WMRNGPYHLQSTDL-UHFFFAOYSA-N n-cyclohexyl-2-[[1-(cyclohexylamino)-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound C1CCCCC1NC(=O)C(C)(C)N=NC(C)(C)C(=O)NC1CCCCC1 WMRNGPYHLQSTDL-UHFFFAOYSA-N 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 150000002892 organic cations Chemical class 0.000 description 1
- 125000000962 organic group Chemical group 0.000 description 1
- 150000001451 organic peroxides Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000013500 performance material Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 229950000688 phenothiazine Drugs 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920000962 poly(amidoamine) Polymers 0.000 description 1
- 229920002493 poly(chlorotrifluoroethylene) Polymers 0.000 description 1
- 229920002492 poly(sulfone) Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002312 polyamide-imide Polymers 0.000 description 1
- 229920006260 polyaryletherketone Polymers 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 239000005023 polychlorotrifluoroethylene (PCTFE) polymer Substances 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920006393 polyether sulfone Polymers 0.000 description 1
- 229920002530 polyetherether ketone Polymers 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920000306 polymethylpentene Polymers 0.000 description 1
- 239000011116 polymethylpentene Substances 0.000 description 1
- 229920012287 polyphenylene sulfone Polymers 0.000 description 1
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 1
- 239000004810 polytetrafluoroethylene Substances 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920002717 polyvinylpyridine Polymers 0.000 description 1
- 150000004032 porphyrins Chemical class 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 description 1
- 229940080818 propionamide Drugs 0.000 description 1
- 229930185107 quinolinone Natural products 0.000 description 1
- 238000003847 radiation curing Methods 0.000 description 1
- 238000007761 roller coating Methods 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 238000000550 scanning electron microscopy energy dispersive X-ray spectroscopy Methods 0.000 description 1
- 238000007650 screen-printing Methods 0.000 description 1
- 238000007767 slide coating Methods 0.000 description 1
- 238000007764 slot die coating Methods 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 239000001119 stannous chloride Substances 0.000 description 1
- 235000011150 stannous chloride Nutrition 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 125000005504 styryl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 125000000446 sulfanediyl group Chemical group *S* 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- 150000003457 sulfones Chemical class 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-N sulfonic acid Chemical group OS(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-N 0.000 description 1
- 150000003462 sulfoxides Chemical class 0.000 description 1
- 239000001117 sulphuric acid Substances 0.000 description 1
- 239000004758 synthetic textile Substances 0.000 description 1
- ANRHNWWPFJCPAZ-UHFFFAOYSA-M thionine Chemical compound [Cl-].C1=CC(N)=CC2=[S+]C3=CC(N)=CC=C3N=C21 ANRHNWWPFJCPAZ-UHFFFAOYSA-M 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 238000006276 transfer reaction Methods 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/44—Ion-selective electrodialysis
- B01D61/445—Ion-selective electrodialysis with bipolar membranes; Water splitting
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D61/00—Processes of separation using semi-permeable membranes, e.g. dialysis, osmosis or ultrafiltration; Apparatus, accessories or auxiliary operations specially adapted therefor
- B01D61/42—Electrodialysis; Electro-osmosis ; Electro-ultrafiltration; Membrane capacitive deionization
- B01D61/44—Ion-selective electrodialysis
- B01D61/46—Apparatus therefor
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0002—Organic membrane manufacture
- B01D67/0009—Organic membrane manufacture by phase separation, sol-gel transition, evaporation or solvent quenching
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D67/00—Processes specially adapted for manufacturing semi-permeable membranes for separation processes or apparatus
- B01D67/0081—After-treatment of organic or inorganic membranes
- B01D67/0088—Physical treatment with compounds, e.g. swelling, coating or impregnation
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/10—Supported membranes; Membrane supports
- B01D69/106—Membranes in the pores of a support, e.g. polymerized in the pores or voids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/12—Composite membranes; Ultra-thin membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D69/00—Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
- B01D69/12—Composite membranes; Ultra-thin membranes
- B01D69/1216—Three or more layers
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D71/00—Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
- B01D71/06—Organic material
- B01D71/76—Macromolecular material not specifically provided for in a single one of groups B01D71/08 - B01D71/74
- B01D71/82—Macromolecular material not specifically provided for in a single one of groups B01D71/08 - B01D71/74 characterised by the presence of specified groups, e.g. introduced by chemical after-treatment
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/20—Manufacture of shaped structures of ion-exchange resins
- C08J5/22—Films, membranes or diaphragms
- C08J5/2206—Films, membranes or diaphragms based on organic and/or inorganic macromolecular compounds
- C08J5/2275—Heterogeneous membranes
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/14—Membrane materials having negatively charged functional groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/16—Membrane materials having positively charged functional groups
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D2325/00—Details relating to properties of membranes
- B01D2325/42—Ion-exchange membranes
Definitions
- This invention relates to bipolar membranes, their preparation processes and their use.
- Ion exchange membranes are used in electrodialysis, electrolysis, production of acids and bases, and a number of other processes.
- the transport of ions through the membranes occurs under the influence of a driving force such as an ion concentration gradient or, alternatively, an electrical potential gradient.
- Ion exchange membranes are generally categorized as bipolar membranes, cation exchange membranes or anion exchange membranes, depending on the charge of their ionic groups.
- Cation exchange membranes comprise negatively charged groups that allow the passage of cations but reject anions
- anion exchange membranes comprise positively charged groups that allow the passage of anions but reject cations.
- a bipolar membrane has both an anionic layer or cation exchanger layer (CEL) and a cationic layer or anion exchange layer (AEL) and thus have both a negatively charged layer and a positively charged layer.
- Some ion exchange membranes and bipolar membranes comprise a porous support, which provides mechanical strength.
- Such membranes are often called “composite membranes” due to the presence of both an ionically charged polymer which discriminates between oppositely charged ions and the porous support which provides mechanical strength.
- Composite membranes are known from, for example, US 4,253,900, which describes a bipolar membrane containing a monobead layer of ion exchange resin.
- WO2017/205458 and the article by McClure in ECS Transactions, 2015 69 (18) pages 35-44 describe a bipolar membrane containing a junction layer of interpenetrating polymer nanofibers or microfibers of anion exchange polymers and cation exchange polymers.
- Other examples of composite membranes are described in e.g. EP3604404, wherein one of the layers comprise an ion exchange resin powder, and US 4,673,454 disclosing the use of an ion exchange resin in an interfacial layer.
- bipolar membranes having improved properties, e.g. high permselectivity, low electrical resistance, good mechanical strength, low swelling under aqueous conditions, stability at extremes of pH and ability to provide acids and bases in high purity. Ideally such bipolar membranes may be produced quickly, efficiently and cheaply.
- a bipolar membrane which has a Constant Phase Element (CPE) of 725 Ohnr 1 .s n or lower when measured at a current density of 25 mA/cm 2 .
- CPE Constant Phase Element
- the Constant Phase Element may be determined by Electrochemical Impedance Spectroscopy (EIS), preferably by a commonly used method such as the Nyquist plot.
- EIS Electrochemical Impedance Spectroscopy
- the CPE is determined using 1M electrolytes, such as H2SO4 and 1 M KOH, at a temperature of 25°C.
- the bipolar membrane preferably comprises less than 0.20 mmol per m 2 of catalysts, more preferably less than 0.10 mmol per m 2 , especially less than 0.02 mmol per m 2 .
- a catalyst is a compound which reduce the potential required for the bipolar membrane to achieve water splitting (without being consumed in the water-splitting process) and/or which reduce the ionic resistance of the bipolar membrane.
- the bipolar membrane comprises less than 0.20 mmol per m 2 of multivalent metal salts, multivalent metal oxides and organometallic compounds, more preferably less than 0.10 mmol per m 2 , especially less than 0.02 mmol per m 2 (as catalyst).
- the bipolar membrane is preferably free from catalysts, e.g.
- polyvinyl alcohol PVA
- polyethylene glycol PEG
- polyethyleneimine PEI
- polyvinylpyridine PVP
- polyacrylic acid PAA
- PAAMA co-polymers of acrylic acid and maleic anhydride
- hyperbranched aliphatic polyesters e.g. BoltornTM H30, BoltornTM H20
- proteins e.g. lysozyme (LYS) or bovine serum albumin (BSA)
- poly(amidoamine) dendrimers At high current density the presence of an effective amount of such catalysts is not desirable because they can reduce ion transport efficiency, i.e.
- the CPE of the bipolar membrane is as low as possible, e.g. preferably less than 700 Ohm -1 .s n , more preferably from 100 to 650 Ohnr 1 .s n , when measured at a current density of 25 mA/cm 2 .
- a low CPE indicates that the newly formed IT and OH- ions are transported selectively and fast through the cation exchange layer (CEL) and anion exchange layer (AEL) of the bipolar membrane (BPM) respectively, instead of being stored at the interface of cationic polymer and anionic polymer resulting in undesired recombination.
- the bipolar membrane comprises: a) a first layer comprising a first polymer or a fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer; b) a second layer comprising a second polymer having ionic groups of the same charge as the charge of the ionic groups of the third polymer; and c) a third layer comprising a polymeric network of (i) a third polymer having ionic groups; and (ii) a fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer; wherein third layer c) is interposed between first layer a) and second layer b).
- the polymeric network of the third polymer and the fourth polymer is co-continuous.
- the third polymer provides a network of pores and the fourth polymer is present within that network of pores.
- the third polymer is obtainable by a process comprising phase separation of the third polymer from a curable composition used to prepare the third polymer.
- the bipolar membrane of the present invention has a large interfacial surface factor (S).
- the interfacial surface factor (S) is a measure for the surface area of the interface at the junction of the third polymer and the fourth polymer within the third layer c).
- the interfacial surface factor (S) is the dimensionless average number of phase changes in the third layer c) per unit length in any direction of the third layer c) multiplied by the thickness of the third layer c) (perpendicular to the main plain of the BPM) expressed in the same unit length.
- phase change is meant the change from cationic polymer to anionic polymer and vice versa.
- the bipolar membrane of the present invention has an interfacial surface factor (S) higher than 1 , more preferably higher than 2, and preferably lower than 4000, more preferably lower than 3000, e.g. from 3 to 1200 or more preferably from 5 to 800.
- S interfacial surface factor
- the first polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer is sometimes abbreviated to “the first polymer”
- the second polymer having ionic groups of the same charge as the charge of the ionic groups of the third polymer is sometimes abbreviated to “the second polymer”
- the third polymer having ionic groups is sometimes abbreviated to “the third polymer”
- fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer is sometimes abbreviated to “the fourth polymer”.
- BPM bipolar membrane
- S interfacial surface factor
- the first polymer is anionic and the third polymer is cationic. In another embodiment the first polymer is cationic and the third polymer is anionic.
- one of the third and the first polymers is a cationic polymer (i.e. carries positively charged groups) and the other is an anionic polymer (i.e. carries negatively charged groups).
- the third layer c) comprises a co-continuous polymeric network of (i) the third polymer having ionic groups and a network of pores; and (ii) a fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer.
- one of the third and fourth polymers is a cationic polymer (i.e. carries positively charged groups) and the other is an anionic polymer (i.e. carries negatively charged groups).
- the third polymer is anionic and the fourth polymer is cationic.
- the third polymer is cationic and the fourth polymer is anionic.
- the third polymer is obtainable by phase-separation of the third polymer from a composition used to prepare the third polymer.
- the third polymer in a form which comprises a network of pores and the pores may be used to receive the fourth polymer (or a curable composition used to prepare the fourth polymer) in order to make the third layer c) and provide a co-continuous polymeric network of (i) the third polymer having ionic groups; and (ii) the fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer and being present within the network of pores of the third polymer.
- the curable composition used to prepare the fourth polymer is identical to the curable composition used to prepare the first polymer.
- the co-continuous polymeric network comprises the third polymer and the fourth polymer, wherein the third polymer provides a network of pores and the fourth polymer is present within that network of pores.
- the third polymer comprises a porous first polymeric domain comprising ionic groups and a network of pores.
- the fourth polymer comprises a second polymeric domain comprising ionic groups having a charge opposite to the charge of the ionic groups of the first polymeric domain.
- the second polymeric domain is located in the pores of the first polymeric domain (i.e. in the network of pores of the third polymer).
- the co-continuous polymeric network preferably comprises two individual, continuous, polymeric domains, one bearing anionic charges and the other bearing cationic charges.
- one of the polymeric domains is phase-separated, e.g. one of the third and fourth polymers, especially the third polymer, is obtained by phase separation from a composition used to prepare that polymer in porous form and the other polymer, i.e. the fourth polymer, fills the pores of that polymer.
- the third and fourth polymers in the third layer (c) are nonmixed, non-encapsulated and preferably they are non-fibrillar.
- the third layer contains one or more than one further polymeric domains each bearing an anionic charge or a cationic charge.
- the fourth polymer is present in the network of pores of the third polymer and in the first layer a).
- the third polymer has the same charge as and/or is chemically similar to the second polymer in the second layer b).
- the chemical composition of the first polymer is the same as or substantially the same as the chemical composition of the fourth polymer.
- the chemical composition of the second polymer is the same as or substantially the same as the chemical composition of the third polymer.
- the third layer c) preferably comprises at least two continuous intermingled polymeric domains (one domain derived from the third polymer and the other domain derived from the fourth polymer) having a large contact area with each other.
- This may be achieved by the third polymer comprising a network of pores and the fourth polymer being different to the third polymer (e.g. one is cationic and the other is anionic) and being present within the network of pores of the third polymer.
- the third polymer comprising a network of pores and the fourth polymer being different to the third polymer (e.g. one is cationic and the other is anionic) and being present within the network of pores of the third polymer.
- the large contact area between the third and fourth polymers present in the third layer is preferably provided by the co-continuous network wherein the two (or more) polymeric domains derived from the third and fourth polymers bear opposite charges (i.e. one domain has anionic charges and the other has cationic charges).
- An advantage of the co-continuous network is that newly produced anions (e.g. OH ) and cations (e.g. H + ) created at the interface between the third and fourth polymers (i.e. the interface of the two polymeric domains) are separated into the individual polymeric domains immediately after their formation, preventing ion recombination.
- the adhesion between the third and fourth polymers i.e.
- adhesion between the first and second polymeric domains) in the third layer c) is extremely strong as a result of the entanglement of the third and fourth polymers, and the large contact area between the third and fourth polymers.
- the strong adhesion between the third and fourth polymers prevents/reduces the so-called ballooning effect in which large water-filled blisters can be formed at the interface between positively and the negatively charged polymers of a bipolar membrane, where OH and H + might recombine (undesirably) to form water.
- the membrane of the present invention preferably comprises an interface between the first layer a) and the third layer c) (a first interface) and an interface between the third layer c) and the second layer b) (a second interface) and preferably both the first interface and the second interface are uninterrupted, without any gaps and/or spaces between the first layer a) and the third layer c) and without any gaps and/or spaces between the third layer c) and the second layer b).
- the third layer c) comprises a blend morphology of two continuous polymeric domains derived from the third and fourth polymers respectively, of which one domain (derived from the fourth polymer) is located within the other domain (derived from the third polymer), forming the abovementioned co-continuous polymeric network (of the fourth polymer within the network of pores of the third polymer).
- each of the first and second polymeric domains is continuous, and at least one of the first and second polymeric domains substantially comprises a single covalently linked carbon backbone such that it is interconnected to itself.
- polymeric domains are not encapsulated, not isolated, not discontinued and are non-fibrillar (e.g. not made by electrospinning).
- the third layer c) preferably comprises a porous support and the third polymer is present within the porous structure of this support.
- the third polymer preferably comprises a network of pores and the fourth polymer is present within those pores (thereby providing the co-continuous polymeric network, e.g. two polymeric domains of which one bears anionic charges and the other cationic charges.
- the two (or more) polymeric domains (one from the third polymer and another from the fourth polymer present within the network of pores of the third polymer) occupy the pores of the porous support and preferably comprise a seamless (third) interface (the first and second interfaces being at the junction of the third layer c) and the first and second layers a) and b) respectively).
- the membrane preferably comprises an interface at the junction of the third layer c) and the first layer a), an interface at the junction of the third layer c) and the second layer b), and a third interface within the third layer c) at the junction of the third polymer and the fourth polymer.
- this third interface is uninterrupted, without any gaps and/or spaces between the third polymer and the fourth polymer.
- this third interface is not an interface between a polymer and fused/compressed fibers, beads, or particles.
- the third layer c) comprises the third polymer and the fourth polymer and the volume fraction of the third polymer or the fourth polymer is defined as the fraction of the volume of the third polymer or the fourth polymer as part of the total volume of the ionically charged polymers in the third layer c), thus excluding a porous support when present.
- the volume fraction of the third polymer in the third layer c) is preferably from 0.1 to 0.9, more preferably from 0.2 to 0.8, especially 0.3 to 0.7, e.g. about 0.4, about 0.5 or about 0.6.
- the third polymer is obtained by a process comprising photopolymerization-induced phase separation, e.g. of the third polymer from a composition used to prepare that polymer.
- a process comprising photopolymerization-induced phase separation, e.g. of the third polymer from a composition used to prepare that polymer.
- the third polymer is formed by a (photo-)polymerization reaction.
- the third polymer comprises a network of pores which has an average pore diameter of less than 5 pm, more preferably less than 2 pm, especially less than 1 pm.
- the pores within the third polymer may then be filled with a (fourth) curable composition and that curable composition may then be cured in order to provide the fourth polymer within the third polymer’s network of pores.
- the third polymer comprises a network of pores and the network of pores is substantially or completely filled with the fourth polymer.
- a third layer c) results in which the third polymer comprises a network of pores which are filled with the (oppositely charged) fourth polymer.
- the third and fourth polymers may therefore provide a co-continuous polymeric network comprising two polymeric domains: one from the third polymer and another from the fourth polymer.
- this co-continuous polymeric network is free from other polymers (except for any polymer present in the porous support).
- the pores present in the third polymer may comprise more than one polymer, e.g. the fourth polymer (derived from a fourth curable composition) and optionally a second polymer (derived from a second curable composition) such that the fourth polymer partly fills the pores of the third polymer and the second polymer is filling the remaining pores.
- the pores in the third polymer may comprise one or more further polymers if desired.
- Fig 1 shows the equivalent circuit used to describe the impedance of a BPM.
- Fig 1 shows the equivalent circuit used to fit the impedance data of the bipolar membrane comprising a first resistor (RQ) and a second resistor (RWDR) in parallel with a constant phase element (CPE) which is equivalent to a capacitor.
- the first resistor Rn represents the resistance from the solution and the membrane and the second resistor RWDR represents the resistance of the water dissociation reaction (WDR).
- Fig. 2 shows a representative Nyquist plot which shows the negative imaginary impedance lm(z) versus the real part of the impedance Re(z).
- the porous supports may be physically and chemically identical to each other or they may be different from one or more of the other porous supports present in the membrane (if any), depending on the properties desired for and intended use of the membrane.
- at least one of the layers a), b) and c) comprises a porous support.
- the membrane of the present invention is preferably a composite membrane.
- a porous support is useful to provide mechanical strength and typically one or more of the layers a), b) and c) comprise a porous support.
- Each porous support may be positioned wholly within a layer or, if desired, at the interface of third layer c) and first layer a) and/or the interface of third layer c) and second layer b).
- a single porous support is present in and common to both the first layer a) and the third layer c).
- layer b) optionally comprises a second porous support.
- the polymer of the relevant layer is preferably present within the pores of the relevant porous support.
- a single porous support is present in and common to both the second layer b) and the third layer c).
- layer a) optionally comprises a second porous support.
- the polymer of the relevant layer is preferably present within the pores of the relevant porous support.
- layers a), b) and c) comprise a porous support.
- layers a) and c) comprise a porous support and layer b) is free from porous supports, or layers b) and c) comprise a porous support and layer a) is free from porous supports, or layers a) and b) comprise a porous support and layer c) is free from porous supports.
- the two layers optionally each comprise a separate support or the two layers comprise the same single support.
- At least third layer c) comprises a porous support.
- third layer c) is partly supported by a first porous support and partly unsupported.
- the membrane comprises a porous support which fully supports first layer a) or second layer b) and partly supports third layer c).
- the remaining layer (layer b) or layer a) as the case may be) is preferably free from porous supports or comprises a second porous support.
- porous supports which may be included in the layers a), b) and/or c) there may be mentioned woven and non-woven synthetic fabrics and extruded films.
- examples include wetlaid and drylaid non-woven material, spunbond and meltblown fabrics and nanofiber webs made from, e.g. polyethylene, polypropylene, polyacrylonitrile, polyvinyl chloride, polyphenylenesulfide, polyester, polyamide, polyaryletherketones such as polyether ether ketone and copolymers thereof.
- Porous supports may also be porous membranes, e.g.
- the porous support(s), when present, each independently have an average thickness of between 10 and 400pm, more preferably between 20 and 150pm and especially between 30 and 100pm.
- the porous support(s), when present, have a porosity of between 30 and 95%.
- the porosity of a support may be determined by a porometer, e.g. a PoroluxTM 1000 from IB-FT GmbH, Germany.
- One or more of the porous supports may be treated to modify its surface energy, e.g. to values above 45 mN/m, preferably above 55mN/m. Suitable treatments include corona discharge treatment, plasma glow discharge treatment, flame treatment, ultraviolet light irradiation treatment, chemical treatment or the like, e.g. for the purpose of improving the wettability of and the adhesiveness to the porous support.
- porous supports are available from a number of sources, e.g. from Freudenberg Filtration Technologies (Novatexx materials), Lydall Performance Materials, Celgard LLC, APorous Inc., SWM (Conwed Plastics, DelStar Technologies), Teijin, Hirose, Mitsubishi Paper Mills Ltd and Sefar AG.
- each porous support independently is a polymeric support.
- Preferred supports comprise a woven or non-woven synthetic fabric or an extruded film without covalently bound ionic groups.
- the first layer a), the second layer b) and the third layer c) of the membrane each independently has an average thickness of between 4pm and 200pm, more preferably of between 5pm and 150pm and especially between 5 and 80pm.
- the third layer c) has a thickness of at least 4pm, more preferably at least 10pm.
- the membrane of the present invention has an average thickness of between 30pm and 600pm, more preferably of between 60pm and 450pm and especially between 90 and 300pm.
- the bipolar membrane of the present invention is especially suitable for uses which require a high current density, e.g. higher than 200mA/cm 2 .
- the first, second, third and fourth polymers are preferably each independently obtained by a process comprising curing a curable composition comprising a curable compound having an ionic group, e.g. an anionic group or a cationic group.
- the first polymer may be obtained from a first curable composition
- the second polymer may be obtained from a second curable composition
- the third polymer may be obtained from a third curable composition
- the fourth polymer may be obtained from a fourth curable composition.
- the ionic groups may be partially or wholly in salt form.
- the curable compound having an ionic group may be rendered curable by the presence of one or more ethylenically unsaturated groups.
- the curable compound having an ionic group preferably comprises an ethylenically unsaturated group and a cationic group or an anionic group.
- Anionic groups have a charge opposite to cationic groups.
- aromatic vinyl groups e.g. styrenic groups
- Preferred anionic groups are acidic groups, for example a sulpho, carboxy and/or phosphate groups, especially sulpho groups.
- the preferred salts are lithium, ammonium, sodium and potassium salts and mixtures comprising two or more thereof.
- Preferred cationic groups are quaternary ammonium groups.
- curable compounds having an anionic group or a quaternary ammonium group are provided below.
- the curable compositions which may be used to prepare the first, second third and fourth polymers preferably further comprise a crosslinking agent, e.g. curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group, in an amount of 1 to 88 wt% (or 1 to 70wt%).
- curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group are provided below.
- the curable compositions which may be used to prepare the first, second third and fourth polymers preferably further comprise a radical initiator, e.g. 0 to 10 wt% of radical initiator.
- a radical initiator e.g. 0 to 10 wt% of radical initiator.
- suitable radical initiators are provided below.
- the curable compositions which may be used to prepare the first, second third and fourth polymers preferably further comprise a solvent, e.g. 0 to 55wt% or 20 to 98 wt% of solvent. Examples of suitable solvents are provided below.
- the first polymer (and optionally the fourth polymer) is obtainable by a process comprising curing a first curable composition comprising:
- the second polymer is obtainable by a process comprising curing a second curable composition comprising:
- (b2) 1 to 88 wt% of a curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group (of the same charge as the charge of the ionic group of the curable compound present in the third curable composition);
- the third polymer is preferably obtained from a process comprising polymerisation-induced phase separation of the third polymer from a third curable composition used to prepare the third polymer.
- This process is particularly useful for providing the third polymer in a form which comprises a network of pores capable of receiving a fourth curable composition (which may be identical to the first curable composition or different to the first curable composition) for preparation of the fourth polymer within the network of pores (and optionally on the surface of the third polymer too, if desired, in order to provide the first layer a) in a very efficient manner).
- the third polymer comprising ionic groups is obtainable by a process comprising curing a third curable composition comprising:
- the charge of the ionic group of components (a3/b3) is the same as the charge of the ionic group of components (a2/b2) and opposite to the charge of the ionic group of components (a1/b1).
- the fourth polymer is obtainable by a process comprising curing a fourth curable composition which falls within the definition provided above for the first curable composition.
- the fourth curable composition may be the same as or different to the first curable composition.
- the fourth curable composition comprises a curable compound having one ethylenically unsaturated group and an ionic group of charge opposite to the charge of the ionic group of the curable compound present in the third curable composition.
- the fourth polymer is obtainable by a process comprising curing a fourth curable composition comprising:
- the amount of each of component (a1), (a2) and (a4) independently is preferably 0 to 40wt%.
- the amount of component (a3) is preferably 0 to 30wt%, especially 0 to 20wt%.
- the amount of each of components (b1 ), (b2) and (b4) independently is preferably 5 to 80wt%, especially 10 to 70wt%.
- the amount of component (b3) is preferably 9 to 65wt%, especially 14 to 59wt%, more especially 19 to 49wt%.
- the curable compositions which may be used to make the first, second, third and fourth polymers preferably comprise a radical initiator (component (c1), (c2), (c3) and (c4)) when it is intended to cure the composition by UV, visible light or thermally.
- a radical initiator component (c1), (c2), (c3) and (c4)
- Alternative methods for curing include electron beam and gamma irradiation. Those methods do not require a radical initiator.
- the amount of component (c1), (c2), (c3) and (c4) present in the relevant compositions is preferably 0 to 2wt%, more preferably (for curing by UV, visible light or thermally) 0.001 to 2wt%, especially 0.005 to 0.9wt%.
- the amount of component (d1), (d2) and (d4) present in the relevant compositions is preferably 20 to 45wt%.
- the amount of component (d3) is preferably 30 to 90wt%, especially 40 to 85wt%, more especially 49 to 78wt%.
- the solvent(s) used as component (d1 ), (d2), (d3) and (d4) are inert, i.e. they do not react with any of the other components of the curable composition.
- Component (d3) is preferably a single solvent.
- Preferably component (d3) is water.
- Component (d3) optionally comprises two or more inert solvents, at least one of which is a solvent for the other components of the curable composition and at least one of which is a non-solvent for the third polymer formed from curing the composition, e.g. by phase separation, thereby forming the third polymer comprising a network of pores capable of receiving the fourth curable composition.
- inert solvents which may be present in the curable compositions include water, alcohol-based solvents, ether-based solvents, amide-based solvents, ketone-based solvents, sulfoxide-based solvents, sulfone-based solvents, nitrile-based solvents and organic phosphorus-based solvents.
- examples of alcohol-based solvents which may be used as or in component (d3) (especially in combination with water) include methanol, ethanol, isopropanol, n-propanol, n-butanol, ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol and mixtures comprising two or more thereof.
- organic solvents which may be used in component (d1 ), (d2), (d3) and (d4) include dimethyl sulfoxide, dimethyl imidazolidinone, sulfolane, N-methyl pyrrolidone, dimethyl formamide, acetonitrile, acetone, 1,4-dioxane, 1,3-dioxolane, tetramethyl urea, hexamethyl phosphoramide, hexamethyl phosphorotriamide, pyridine, propionitrile, butanone, cyclohexanone, tetrahydrofuran, tetrahydropyran, 2-methyltetrahydrofuran, ethylene glycol diacetate, cyclopentylmethylether, methylethylketone, ethyl acetate, y- butyrolactone and mixtures comprising two or more thereof.
- Dimethyl sulfoxide, N-methyl pyrrolidone, dimethyl formamide, dimethyl imidazolidinone, sulfolane, acetone, cyclopentylmethylether, methylethylketone, acetonitrile, tetrahydrofuran, 2- methyltetrahydrofuran and mixtures comprising two or more thereof are preferable.
- component (d3) comprises at least one of the solvents from list (i) below and at least one of the solvents from list (ii) below wherein the at least two solvents are different: list (i): iso-propanol, methanol, ethanol, acetone, tetramethyl urea, hexamethyl phosphoramide, hexamethyl phosphorotriamide, butanone, cyclohexanone, methylethylketone, tetrahydrofuran, tetrahydropyran, 2-methyltetrahydrofuran, cyclopentylmethylether, propionitrile, acetonitrile, 1 ,4-dioxane, 1 ,3-dioxolane, ethyl acetate, y- butyrolactone; and list (ii): water, glycerol, ethylene glycol, dimethyl sulfoxide, sulpholane, dimethyl imidazolidin
- component (d1 ), (d2), (d3) and (d4) comprises water and one or more other solvents from list (i).
- one of the first curable composition and the second curable composition comprises a curable compound having an ethylenically unsaturated group and an anionic group and the other comprises a curable compound having an ethylenically unsaturated group and a cationic group.
- one of the third curable composition and the fourth curable composition comprises a curable compound having an ethylenically unsaturated group and an anionic group and the other comprises a curable compound having an ethylenically unsaturated group and a cationic group.
- curable compounds having an ethylenically unsaturated group and an anionic group or cationic group include the following compounds of Formula (A), (B), (CL), (SM), (MA), (MB-a), (C), (ACL-A), (ACL-B), (ACL-C), and/or (AM-B):
- R A1 to R A3 each independently represent a hydrogen atom or an alkyl group
- R B1 to R B7 each independently represent an alkyl group or an aryl group
- Z A1 to Z A3 each independently represent -O- or -NRa-, wherein Ra represents a hydrogen atom or an alkyl group;
- L A1 to L A3 each independently represent an alkylene group, an arylene group or a divalent linking group of a combination thereof;
- R x represents an alkylene group, an alkenylene group, an alkynylene group, an arylene group, or a divalent linking group of a combination thereof; and X A1 to X A3 each independently represent an organic or inorganic anion, preferably a halogen ion or an aliphatic or aromatic carboxylic acid ion.
- Examples of compounds of Formula (A) or (B) include: Synthesis methods can be found in e.g. US2015/0353721 , US2016/0367980 and US2014/0378561. wherein in Formulae (CL) and (SM):
- L 1 represents an alkylene group or an alkenylene group
- R a , R b , R c , and R d each independently represent a linear or branched alkyl group or an aryl group
- R a and R b , and/or R c and R d may form a ring by being bonded to each other;
- R 1 , R 2 , and R 3 each independently represent a linear or branched alkyl group or an aryl group,
- R 1 and R 2 , or R 1 , R 2 and R 3 may form an aliphatic heterocycle by being bonded to each other; n1 , n2 and n3 each independently represent an integer of 1 to 10; and Xi , X2 and X3 each independently represent an organic or inorganic anion.
- R A1 represents a hydrogen atom or an alkyl group
- Z 1 represents -O- or -NRa-, wherein Ra represents a hydrogen atom or an alkyl group
- M + represents an organic or inorganic cation, preferably a hydrogen ion or an alkali metal ion;
- R ⁇ represents a hydrogen atom or an alkyl group
- R A4 represents an organic group comprising a sulphonic acid group and having no ethylenically unsaturated group
- Z 2 represents -NRa-, wherein Ra represents a hydrogen atom or an alkyl group preferably a hydrogen atom.
- Ra represents a hydrogen atom or an alkyl group preferably a hydrogen atom.
- L 1 represents an alkylene group
- n represents an integer of 1 to 3, preferably 1 or 2
- m represents an integer of 1 or 2;
- L 2 represents an n-valent linking group
- R 1 represents a hydrogen atom or an alkyl group
- R 2 represents -SOs I T or -SO3R 3 ; in case of plural R 2 ‘s, each R 2 independently represents - SO 3 M + or -SO3R 3 ;
- M + represents a hydrogen ion, an inorganic ion, or an organic ion
- R 3 represents an alkyl group or an aryl group.
- Examples of formula (C) include: Synthesis methods can be found in EP3187516. M-B) wherein in Formulas (ACL-A), (ACL-B), (ACL-C) and (AM-B), each of R and R' independently represents a hydrogen atom or an alkyl group; LL represents a single bond or a bivalent linking group; each of LL 1 , LL 1 ', LL 2 , and LL 2 ' independently represents a single bond or a bivalent linking group; and each of A and A' independently represents a sulfo group in free acid or salt form; and m represents 1 or 2.
- Examples of formula (ACL-A), (ACL-B), (ACL-C) and (AM-B) include:
- the curable compositions may be cured by any suitable process, including thermal curing, photocuring, electron beam (EB) radiation, gamma radiation, and combinations of the foregoing.
- the curable compositions are preferably cured by photocuring, e.g. by irradiating the curable compositions by ultraviolet of visible light and thereby causing the curable components present in the compositions to polymerise.
- thermal initiators examples include 2,2’-azobis(2-methylpropionitrile) (AIBN), 4,4’-azobis(4-cyanovaleric acid), 2,2’-azobis(2,4-dimethyl valeronitrile), 2,2’-azobis(2-methylbutyronitrile), 1,T- azobis(cyclohexane-1 -carbonitrile), 2,2’-azobis(4-methoxy-2,4-dimethyl valeronitrile), dimethyl 2,2’-azobis(2-methylpropionate), 2,2’-azobis[N-(2-propenyl)-2-methylpropionamide, 1-[(1- cyano-1-methylethyl)azo] formamide, 2,2'-Azobis(N-butyl-2-methylpropionamide), 2,2'- Azobis(N-cyclohexyl-2-methylpropionamide), 2,2'-Azobis(2-methylpropionamidine) dihydrochloride, 2,2’-azobis(2-methylpropionit
- Suitable photoinitiators which may be included in the curable compositions include aromatic ketones, acylphosphine compounds, aromatic onium salt compounds, organic peroxides, thio compounds, hexaarylbiimidazole compounds, ketoxime ester compounds, borate compounds, azinium compounds, metallocene compounds, active ester compounds, compounds having a carbon halogen bond, and an alkyl amine compounds.
- Preferred examples of the aromatic ketones, the acylphosphine oxide compound, and the thiocompound include compounds having a benzophenone skeleton or a thioxanthone skeleton described in "RADIATION CURING IN POLYMER SCIENCE AND TECHNOLOGY", pp.77- 117 (1993).
- More preferred examples thereof include an alpha-thiobenzophenone compound described in JP1972-6416B (JP-S47-6416B), a benzoin ether compound described in JP1972- 3981 B (JP-S47-3981B), an alpha-substituted benzoin compound described in JP1972-22326B (JP-S47-22326B), a benzoin derivative described in JP1972-23664B (JP-S47-23664B), an aroylphosphonic acid ester described in JP1982-30704A (JP-S57-30704A), dialkoxybenzophenone described in JP1985-26483B (JP-S60-26483B), benzoin ethers described in JP1985-26403B (JP-S60-26403B) and JP1987-81345A (JPS62-81345A), alphaamino benzophenones described in JP1989-34242B (JP H01-34242B),
- photoinitiators described in JP2008-105379A and JP2009- 114290A are also preferable.
- photoinitiators described in pp. 65 to 148 of "Ultraviolet Curing System” written by Kato Kiyomi may be used.
- Especially preferred photoinitiators include Norrish Type II photoinitiators having an absorption maximum at a wavelength longer than 380nm, when measured in one or more of the following solvents at a temperature of 23°C: water, ethanol and toluene.
- Examples include a xanthene, flavin, curcumin, porphyrin, anthraquinone, phenoxazine, camphorquinone, phenazine, acridine, phenothiazine, xanthone, thioxanthone, thioxanthene, acridone, flavone, coumarin, fluorenone, quinoline, quinolone, naphtaquinone, quinolinone, arylmethane, azo, benzophenone, carotenoid, cyanine, phtalocyanine, dipyrrin, squarine, stilbene, styryl, triazine or anthocyanin-derived photoinitiator.
- the curable compositions may be applied continuously to moving supports, preferably by means of a manufacturing unit comprising curable composition application stations, one or more curing stations comprising irradiation source(s) for curing the compositions, a membrane collecting station and a means for moving the supports from the curable composition application stations to the curing station(s) and to the membrane collecting station.
- a manufacturing unit comprising curable composition application stations, one or more curing stations comprising irradiation source(s) for curing the compositions, a membrane collecting station and a means for moving the supports from the curable composition application stations to the curing station(s) and to the membrane collecting station.
- the curable composition application stations may be located at an upstream position relative to the curing station(s) and the curing station(s) is/are located at an upstream position relative to the membrane collecting station.
- Examples of application techniques include slot die coating, slide coating, air knife coating, roller coating, screen- printing, and dipping.
- it might be necessary to remove excess coating from the substrate by, for example, roll-to-roll squeeze, roll-to-blade or blade-to-roll squeeze, blade-to-blade squeeze or removal using coating bars.
- Curing by ultraviolet of visible light can occur at wavelengths between 100 nm and 800 nm using doses between 40 and 20000 mJ/cm 2 .
- Thermal curing preferably takes place in the range between 20°C and 100°C for 0 to 20 h.
- a process for preparing a bipolar membrane having a CPE of 725 Ohrrr 1 .s n or lower comprising the following steps:
- a first layer a) comprising a first polymer or a fourth polymer, in each case having ionic groups of charge opposite to the charge of the ionic groups of the third polymer
- a second layer b) comprising a second polymer having ionic groups of the same charge as the charge of the ionic groups of the third polymer
- a third layer c) comprising a co-continuous polymeric network of (i) the third polymer having ionic groups; and (ii) the fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer and being present within the network of pores of the third polymer; wherein third layer c) is interposed between first layer a) and second layer b).
- step (i) in step (i) the first curable composition is not provided and in step (vi) contacting the first side of the base layer with the fourth curable composition provides a layer of the fourth curable composition on the first side of the base layer (thus it is not necessary to contact the first side of the base layer with a first curable composition such that a layer of the first curable composition is provided on the first side of the base layer because the fourth curable composition provides the first layer a) in addition to the fourth polymer present in third layer c)).
- step (iv) a layer of the fourth curable composition is provided on the first side of the base layer and in step (vi) this layer is contacted with the first curable composition such that a layer of the first curable composition is provided on the layer of fourth curable composition present on the first side of the base layer, e.g. if the layer of fourth curable composition is very thin.
- the process of the second aspect of the present invention preferably provides a membrane according to the first aspect of the present invention.
- one of the first layer a) and the second layer b) comprises a porous support. This may be achieved by including a porous support in the first curable composition or second curable composition prior to curing during the above process.
- step (ii) of the process further comprises placing the porous support impregnated with the third curable composition between transparent foils to give a sandwich of the impregnated porous support and two foils and then squeezing the sandwich, e.g. between rollers or blades, to remove any excess of third curable composition.
- the transparent foils may be removed before performing step (iv).
- curing of the third curable composition in step (iii) is performed under an inert atmosphere, e.g. under nitrogen, carbon dioxide or argon gas.
- a method for using) the bipolar membranes according to the first aspect of the present invention for use in various applications, including recovery and production of organic and inorganic acids and bases (e.g. ammonia, ethanolamine, lithium hydroxide, gluconic acid, formic acid, amino acids, sulphuric acid), production of oligosaccharides and proteins, and capture of CO2 and SO2 from flue gases.
- organic and inorganic acids and bases e.g. ammonia, ethanolamine, lithium hydroxide, gluconic acid, formic acid, amino acids, sulphuric acid
- production of oligosaccharides and proteins e.g. CO2 and SO2 from flue gases.
- a bipolar electrodialysis device comprising one or more bipolar membranes according to the first aspect of the present invention.
- Second and third curable compositions were prepared by mixing the components indicated in Table 2.
- the first curable composition was also used as fourth curable composition.
- a 100 pm thick layer of the third curable composition was applied to a transparent PET foil sheet using a Meyer bar.
- a porous support (FO2223-10C) was applied to the layer of the third curable composition, thereby becoming impregnated with the third curable composition.
- a second transparent PET foil sheet was applied to the impregnated porous support to provide a sandwich of the impregnated porous support between the two transparent foils. Gently all air was squeezed out of the porous support using a roller.
- the sandwich of the impregnated porous support between the two transparent foils was irradiated using a Light Hammer LH10 from Fusion UV Systems fitted with a D-bulb working at 60% intensity at a speed of 5 m/min in order to cure the third curable composition present in the porous support.
- the transparent PET foils were removed and the cured product was allowed to dry in the air at room temperature to give a base layer (i.e. a porous support comprising a third polymer comprising ionic groups and a network of pores) having a first side and a second side.
- the first curable composition was applied to a transparent PET foil using a 80 pm Meyer bar. Then the base layer prepared as described above, was placed on top of the layer of first curable composition with the first side of the base layer contacting the first curable composition whereupon a part of the first composition (which in this case doubles-up as fourth composition) entered into the pores of the third polymer. This gave a base layer impregnated with the first curable composition and provided a layer of the first curable composition on the first side of the base layer.
- the base layer impregnated with the first curable composition and having a layer of the first composition on its first side was irradiated on the second side of the base layer (i.e. the side without the first curable composition) using a Light Hammer LH10 from Fusion UV Systems fitted with a D-bulb working at 50% intensity at a speed of 5 m/min.
- the resulting cured film was a laminate of layer a) and layer c) in which the pores of the third polymer were filled with cured first curable composition.
- a 100 pm layer of the second curable composition was applied to the second side of the laminate of layer a) and layer c) which was free from layer a) using a Meyer bar and a second porous support (FO2223-10C) was applied to the layer of the second curable composition. After 5 seconds excess second curable composition was removed using a 4 pm Meyer bar.
- the resulting product was irradiated on both sides using a Light Hammer LH10 from Fusion UV Systems fitted with a D-bulb working at 50% intensity at a speed of 5 m/min in order to cure the second curable composition.
- the PET foil was removed to give a bipolar, composite membrane according to the first aspect of the present invention comprising the first layer a), the second layer b) and the third layer c) interposed between the first layer a) and the second layer b).
- Comparative Example BPM2 was prepared using the same method as used for Example 1 (BPM 1) except that a catalyst was applied as described below.
- the base layer of the comparative example Prior to contacting the base layer with the layer of first curable composition the base layer of the comparative example (BPM2) was dipped in a catalyst solution comprising 1.35wt% of tin(ll)chloride (stannous chloride) in a slightly acidic aqueous solution, and allowed to dry at room temperature. Subsequently the base layer was dipped in a 0.12N NaOH solution to precipitate the catalyst and was allowed to dry at room temperature.
- tin(ll)chloride stannous chloride
- CPE Constant Phase Element
- Z is the impedance of the equivalent circuit
- Rn represents the resistance from the solution and the membrane;
- WDR represents the resistance of the water dissociation reaction (WDR);
- j indicates an imaginary number;
- w is the frequency applied;
- n is a non-ideality factor illustrating the degree of non-ideality of the element;
- CPE is the constant phase element
- Re(z) is the real part of the impedance
- Im (z) is the imaginary part of the impedance
- the EIS set-up consisted of a two-chamber flow cell and contained two Ag/AgCI reference electrodes and two electrodes (a working and a counter electrode) consisting of two Pt coated titanium discs of 16 cm 2 and 1 mm in thickness.
- the reference electrodes were connected through a 3M KCI salt bridge using Haber-Luggin capillaries.
- the entire set-up was placed in a Faraday cage to increase the stability of the measurements and to reduce noise.
- An alternating current in the frequency range of 10kHz to 0,01Hz was applied using an impedance analyzer (Metrohm Autolab BV) as a galvanostat. The amplitude was set at 10% of the initial DC applied.
- Aqueous solutions of 1 M H2SO4 and 1 M KOH were used as the electrolytes, which were infused at 4 mL/s each.
- the temperature of the electrolytes was controlled at 25°C.An active surface area of 7 cm 2 of each bipolar membrane sample was used for the measurement, with the CEL facing the cathode and the acidic stream and AEL facing the anode and the base stream.
- the arrangement from anode to cathode was as follows: (CMX - spacer (base compartment) - BPM - spacer (acid compartment) - AMX).
- the electrode rinse solution used was also 0.5M NaCI.
- the BPM membrane active area was 37.84 cm 2 .
- the electrolyte flows were controlled by peristaltic pumps, where the volumetric flows of the acid and base compartments were set to 30 ml/min (6 cm/s), while that of the electrode rinse solution was set to 250 ml/min (50 cm/s).
- the test was conducted at ambient temperature (23°C) and the content of the acid compartment was collected and weighed and subsequently titrated to determine the number of protons produced. The average of four independent measurements was used to calculate current efficiency.
- the system was run in the specified conditions for 12 minutes prior to start sample collection.
- the interfacial surface factor (S) may be determined by counting the number of changes from an element characteristic for the third polymer to an element characteristic for the fourth polymer and vice versa, multiplied by the thickness of the third layer.
- the analysis may be obtained from a SEM-EDX mapping of a cross-section of the third layer.
- the thickness of the third layer may be determined by cutting through the layer and measuring its thickness using scanning electron microscopy (SEM).
- the CPE of BPM1 is lower than that of BPM2, demonstrating that the H + and OH- ions are transported more efficiently away from the interface.
- the membrane without catalyst, BPM2 has a lower CPE, indicating that at higher current densities the membrane without catalyst has a higher ion transport efficiency than the membrane with catalyst.
Landscapes
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Water Supply & Treatment (AREA)
- Manufacturing & Machinery (AREA)
- Health & Medical Sciences (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Materials Engineering (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Separation Using Semi-Permeable Membranes (AREA)
Abstract
The present invention relates to a bipolar membrane which has a Constant Phase Element (CPE) of 725 Ohnr-1.sn or lower when measured at a current density of 25 mA/cm2, to a process for preparing the bipolar membrane, to applications the bipolar membrane may be used in, and to devices comprising the bipolar membrane.
Description
MEMBRANES
This invention relates to bipolar membranes, their preparation processes and their use. Ion exchange membranes are used in electrodialysis, electrolysis, production of acids and bases, and a number of other processes. Typically the transport of ions through the membranes occurs under the influence of a driving force such as an ion concentration gradient or, alternatively, an electrical potential gradient.
Ion exchange membranes are generally categorized as bipolar membranes, cation exchange membranes or anion exchange membranes, depending on the charge of their ionic groups. Cation exchange membranes comprise negatively charged groups that allow the passage of cations but reject anions, while anion exchange membranes comprise positively charged groups that allow the passage of anions but reject cations. A bipolar membrane (BPM) has both an anionic layer or cation exchanger layer (CEL) and a cationic layer or anion exchange layer (AEL) and thus have both a negatively charged layer and a positively charged layer.
Some ion exchange membranes and bipolar membranes comprise a porous support, which provides mechanical strength. Such membranes are often called “composite membranes” due to the presence of both an ionically charged polymer which discriminates between oppositely charged ions and the porous support which provides mechanical strength.
Composite membranes are known from, for example, US 4,253,900, which describes a bipolar membrane containing a monobead layer of ion exchange resin. WO2017/205458 and the article by McClure in ECS Transactions, 2015 69 (18) pages 35-44 describe a bipolar membrane containing a junction layer of interpenetrating polymer nanofibers or microfibers of anion exchange polymers and cation exchange polymers. Other examples of composite membranes are described in e.g. EP3604404, wherein one of the layers comprise an ion exchange resin powder, and US 4,673,454 disclosing the use of an ion exchange resin in an interfacial layer. There is a desire to provide bipolar membranes having improved properties, e.g. high permselectivity, low electrical resistance, good mechanical strength, low swelling under aqueous conditions, stability at extremes of pH and ability to provide acids and bases in high purity. Ideally such bipolar membranes may be produced quickly, efficiently and cheaply.
According to a first aspect of the present invention there is provided a bipolar membrane which has a Constant Phase Element (CPE) of 725 Ohnr1.sn or lower when measured at a current density of 25 mA/cm2.
The Constant Phase Element (CPE) may be determined by Electrochemical Impedance Spectroscopy (EIS), preferably by a commonly used method such as the Nyquist plot.
Preferably the CPE is determined using 1M electrolytes, such as H2SO4 and 1 M KOH, at a temperature of 25°C.
The bipolar membrane preferably comprises less than 0.20 mmol per m2 of catalysts, more preferably less than 0.10 mmol per m2, especially less than 0.02 mmol per m2. A catalyst is a compound which reduce the potential required for the bipolar membrane to achieve water splitting (without being consumed in the water-splitting process) and/or which reduce the ionic
resistance of the bipolar membrane. Preferably the bipolar membrane comprises less than 0.20 mmol per m2 of multivalent metal salts, multivalent metal oxides and organometallic compounds, more preferably less than 0.10 mmol per m2, especially less than 0.02 mmol per m2 (as catalyst). In one embodiment the bipolar membrane is preferably free from catalysts, e.g. free from multivalent metal salts, multivalent metal oxides, organometallic compounds, polyvinyl alcohol (PVA), polyethylene glycol (PEG), polyethyleneimine (PEI), polyvinylpyridine, (PVP), polyacrylic acid (PAA), co-polymers of acrylic acid and maleic anhydride (PAAMA), hyperbranched aliphatic polyesters (e.g. Boltorn™ H30, Boltorn™ H20), proteins (e.g. lysozyme (LYS) or bovine serum albumin (BSA)) and poly(amidoamine) dendrimers. At high current density the presence of an effective amount of such catalysts is not desirable because they can reduce ion transport efficiency, i.e. at high current density the rate of water splitting is high and the presence of a catalyst would increase the rate of the water splitting reaction even further thereby exceeding the capacity of the system to transport the formed ions away from the interface, resulting in undesired recombination of protons and hydroxide ions.
Preferably the CPE of the bipolar membrane is as low as possible, e.g. preferably less than 700 Ohm-1.sn, more preferably from 100 to 650 Ohnr1.sn, when measured at a current density of 25 mA/cm2. A low CPE indicates that the newly formed IT and OH- ions are transported selectively and fast through the cation exchange layer (CEL) and anion exchange layer (AEL) of the bipolar membrane (BPM) respectively, instead of being stored at the interface of cationic polymer and anionic polymer resulting in undesired recombination.
Preferably the bipolar membrane comprises: a) a first layer comprising a first polymer or a fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer; b) a second layer comprising a second polymer having ionic groups of the same charge as the charge of the ionic groups of the third polymer; and c) a third layer comprising a polymeric network of (i) a third polymer having ionic groups; and (ii) a fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer; wherein third layer c) is interposed between first layer a) and second layer b).
Preferably in the third layer the polymeric network of the third polymer and the fourth polymer is co-continuous.
Preferably the third polymer provides a network of pores and the fourth polymer is present within that network of pores. Preferably the third polymer is obtainable by a process comprising phase separation of the third polymer from a curable composition used to prepare the third polymer.
Preferably the bipolar membrane of the present invention has a large interfacial surface factor (S). The interfacial surface factor (S) is a measure for the surface area of the interface at the junction of the third polymer and the fourth polymer within the third layer c). The interfacial surface factor (S) is the dimensionless average number of phase changes in the third layer c) per unit length in any direction of the third layer c) multiplied by the thickness of the third layer c) (perpendicular to the main plain of the BPM) expressed in the same unit length. With phase change is meant the change from cationic polymer to anionic polymer and
vice versa. Preferably the bipolar membrane of the present invention has an interfacial surface factor (S) higher than 1 , more preferably higher than 2, and preferably lower than 4000, more preferably lower than 3000, e.g. from 3 to 1200 or more preferably from 5 to 800.
In this document (including its claims), the verb "comprise" and its conjugations is used in its non-limiting sense to mean that items following the word are included, but items not specifically mentioned are not excluded. In addition, reference to an element by the indefinite article "a" or "an" does not exclude the possibility that more than one of the elements is present, unless the context clearly requires that there be one and only one of the elements. The indefinite article "a" or "an" thus usually means "at least one". Also in this specification the first polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer is sometimes abbreviated to “the first polymer”, the second polymer having ionic groups of the same charge as the charge of the ionic groups of the third polymer is sometimes abbreviated to “the second polymer”, the third polymer having ionic groups is sometimes abbreviated to “the third polymer” and fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer is sometimes abbreviated to “the fourth polymer”. The term “bipolar membrane” is often abbreviated to “BPM” or just “membrane” when used in relation to the present invention. The term “interfacial surface factor (S)” may be abbreviated to “factor S”.
In one embodiment the first polymer is anionic and the third polymer is cationic. In another embodiment the first polymer is cationic and the third polymer is anionic.
In order to achieve the two opposite charges required for the third polymer and the first polymer, one of the third and the first polymers is a cationic polymer (i.e. carries positively charged groups) and the other is an anionic polymer (i.e. carries negatively charged groups).
Preferably the third layer c) comprises a co-continuous polymeric network of (i) the third polymer having ionic groups and a network of pores; and (ii) a fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer.
In order to achieve the two opposite charges required for the third polymer and the fourth polymer, one of the third and fourth polymers is a cationic polymer (i.e. carries positively charged groups) and the other is an anionic polymer (i.e. carries negatively charged groups). In one embodiment the third polymer is anionic and the fourth polymer is cationic. In another embodiment the third polymer is cationic and the fourth polymer is anionic.
In a preferred embodiment the third polymer is obtainable by phase-separation of the third polymer from a composition used to prepare the third polymer. In this way one may obtain the third polymer in a form which comprises a network of pores and the pores may be used to receive the fourth polymer (or a curable composition used to prepare the fourth polymer) in order to make the third layer c) and provide a co-continuous polymeric network of (i) the third polymer having ionic groups; and (ii) the fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer and being present within the network of pores of the third polymer.
In one embodiment the curable composition used to prepare the fourth polymer is identical to the curable composition used to prepare the first polymer. In this way one may obtain a membrane in which the first polymer is identical to the fourth polymer. Preferably the
co-continuous polymeric network comprises the third polymer and the fourth polymer, wherein the third polymer provides a network of pores and the fourth polymer is present within that network of pores.
Preferably the third polymer comprises a porous first polymeric domain comprising ionic groups and a network of pores. Preferably the fourth polymer comprises a second polymeric domain comprising ionic groups having a charge opposite to the charge of the ionic groups of the first polymeric domain. In this embodiment the second polymeric domain is located in the pores of the first polymeric domain (i.e. in the network of pores of the third polymer).
The co-continuous polymeric network preferably comprises two individual, continuous, polymeric domains, one bearing anionic charges and the other bearing cationic charges. Preferably one of the polymeric domains is phase-separated, e.g. one of the third and fourth polymers, especially the third polymer, is obtained by phase separation from a composition used to prepare that polymer in porous form and the other polymer, i.e. the fourth polymer, fills the pores of that polymer. Preferably the third and fourth polymers in the third layer (c) are nonmixed, non-encapsulated and preferably they are non-fibrillar. Optionally the third layer contains one or more than one further polymeric domains each bearing an anionic charge or a cationic charge.
In a preferred embodiment the fourth polymer is present in the network of pores of the third polymer and in the first layer a). In another preferred embodiment, the third polymer has the same charge as and/or is chemically similar to the second polymer in the second layer b).
In a preferred embodiment the chemical composition of the first polymer is the same as or substantially the same as the chemical composition of the fourth polymer.
In another preferred embodiment the chemical composition of the second polymer is the same as or substantially the same as the chemical composition of the third polymer.
The third layer c) preferably comprises at least two continuous intermingled polymeric domains (one domain derived from the third polymer and the other domain derived from the fourth polymer) having a large contact area with each other. This may be achieved by the third polymer comprising a network of pores and the fourth polymer being different to the third polymer (e.g. one is cationic and the other is anionic) and being present within the network of pores of the third polymer. As a result of this large contact area between the two (or more) polymers present in the third layer and, when the membrane is used as a bipolar membrane, the amount of water molecules that is dissociated into IT and OH per unit of time is increased and thereby the productivity of the bipolar membrane is also increased.
The large contact area between the third and fourth polymers present in the third layer is preferably provided by the co-continuous network wherein the two (or more) polymeric domains derived from the third and fourth polymers bear opposite charges (i.e. one domain has anionic charges and the other has cationic charges). An advantage of the co-continuous network is that newly produced anions (e.g. OH ) and cations (e.g. H+) created at the interface between the third and fourth polymers (i.e. the interface of the two polymeric domains) are separated into the individual polymeric domains immediately after their formation, preventing ion recombination. In addition, the adhesion between the third and fourth polymers (i.e.
adhesion between the first and second polymeric domains) in the third layer c) is extremely strong as a result of the entanglement of the third and fourth polymers, and the large contact area between the third and fourth polymers. The strong adhesion between the third and fourth polymers prevents/reduces the so-called ballooning effect in which large water-filled blisters can be formed at the interface between positively and the negatively charged polymers of a bipolar membrane, where OH and H+ might recombine (undesirably) to form water.
The membrane of the present invention preferably comprises an interface between the first layer a) and the third layer c) (a first interface) and an interface between the third layer c) and the second layer b) (a second interface) and preferably both the first interface and the second interface are uninterrupted, without any gaps and/or spaces between the first layer a) and the third layer c) and without any gaps and/or spaces between the third layer c) and the second layer b).
In one embodiment the third layer c) comprises a blend morphology of two continuous polymeric domains derived from the third and fourth polymers respectively, of which one domain (derived from the fourth polymer) is located within the other domain (derived from the third polymer), forming the abovementioned co-continuous polymeric network (of the fourth polymer within the network of pores of the third polymer).
Preferably each of the first and second polymeric domains is continuous, and at least one of the first and second polymeric domains substantially comprises a single covalently linked carbon backbone such that it is interconnected to itself.
Preferably the polymeric domains are not encapsulated, not isolated, not discontinued and are non-fibrillar (e.g. not made by electrospinning).
In the present invention the third layer c) preferably comprises a porous support and the third polymer is present within the porous structure of this support. The third polymer preferably comprises a network of pores and the fourth polymer is present within those pores (thereby providing the co-continuous polymeric network, e.g. two polymeric domains of which one bears anionic charges and the other cationic charges. The two (or more) polymeric domains (one from the third polymer and another from the fourth polymer present within the network of pores of the third polymer) occupy the pores of the porous support and preferably comprise a seamless (third) interface (the first and second interfaces being at the junction of the third layer c) and the first and second layers a) and b) respectively). Thus the membrane preferably comprises an interface at the junction of the third layer c) and the first layer a), an interface at the junction of the third layer c) and the second layer b), and a third interface within the third layer c) at the junction of the third polymer and the fourth polymer. Preferably this third interface is uninterrupted, without any gaps and/or spaces between the third polymer and the fourth polymer. Preferably this third interface is not an interface between a polymer and fused/compressed fibers, beads, or particles.
Preferably the third layer c) comprises the third polymer and the fourth polymer and the volume fraction of the third polymer or the fourth polymer is defined as the fraction of the volume of the third polymer or the fourth polymer as part of the total volume of the ionically charged polymers in the third layer c), thus excluding a porous support when present. The
volume fraction of the third polymer in the third layer c) is preferably from 0.1 to 0.9, more preferably from 0.2 to 0.8, especially 0.3 to 0.7, e.g. about 0.4, about 0.5 or about 0.6.
In one embodiment the third polymer is obtained by a process comprising photopolymerization-induced phase separation, e.g. of the third polymer from a composition used to prepare that polymer. This preference arises because such a process is particularly good at providing a third polymer which comprises a network of pores capable of receiving the fourth (oppositely charged) polymer or a curable composition for preparing the fourth (oppositely charged) polymer. In this process, preferably the third polymer is formed by a (photo-)polymerization reaction.
Preferably, the third polymer comprises a network of pores which has an average pore diameter of less than 5 pm, more preferably less than 2 pm, especially less than 1 pm. The pores within the third polymer may then be filled with a (fourth) curable composition and that curable composition may then be cured in order to provide the fourth polymer within the third polymer’s network of pores. In a preferred embodiment the third polymer comprises a network of pores and the network of pores is substantially or completely filled with the fourth polymer. As a consequence, a third layer c) results in which the third polymer comprises a network of pores which are filled with the (oppositely charged) fourth polymer. The third and fourth polymers may therefore provide a co-continuous polymeric network comprising two polymeric domains: one from the third polymer and another from the fourth polymer. In a preferred embodiment this co-continuous polymeric network is free from other polymers (except for any polymer present in the porous support). In one embodiment there are covalent bonds connecting the third and fourth polymers together. In fact the pores present in the third polymer may comprise more than one polymer, e.g. the fourth polymer (derived from a fourth curable composition) and optionally a second polymer (derived from a second curable composition) such that the fourth polymer partly fills the pores of the third polymer and the second polymer is filling the remaining pores. Additionally, the pores in the third polymer may comprise one or more further polymers if desired.
BRIEF DESCRIPTION OF THE DRAWINGS:
Fig 1 shows the equivalent circuit used to describe the impedance of a BPM.
Fig 1 shows the equivalent circuit used to fit the impedance data of the bipolar membrane comprising a first resistor (RQ) and a second resistor (RWDR) in parallel with a constant phase element (CPE) which is equivalent to a capacitor. The first resistor Rn represents the resistance from the solution and the membrane and the second resistor RWDR represents the resistance of the water dissociation reaction (WDR).
Fig. 2 shows a representative Nyquist plot which shows the negative imaginary impedance lm(z) versus the real part of the impedance Re(z).
When the membrane comprises more than one porous support, the porous supports may be physically and chemically identical to each other or they may be different from one or more of the other porous supports present in the membrane (if any), depending on the properties desired for and intended use of the membrane.
Preferably at least one of the layers a), b) and c) comprises a porous support. Thus, the membrane of the present invention is preferably a composite membrane. A porous support is useful to provide mechanical strength and typically one or more of the layers a), b) and c) comprise a porous support. Each porous support may be positioned wholly within a layer or, if desired, at the interface of third layer c) and first layer a) and/or the interface of third layer c) and second layer b).
In one embodiment, a single porous support is present in and common to both the first layer a) and the third layer c). In this embodiment, layer b) optionally comprises a second porous support. In each case, the polymer of the relevant layer is preferably present within the pores of the relevant porous support.
In another embodiment, a single porous support is present in and common to both the second layer b) and the third layer c). In this embodiment, layer a) optionally comprises a second porous support. In each case, the polymer of the relevant layer is preferably present within the pores of the relevant porous support.
Optionally only two of layers a), b) and c) comprise a porous support. For example, layers a) and c) comprise a porous support and layer b) is free from porous supports, or layers b) and c) comprise a porous support and layer a) is free from porous supports, or layers a) and b) comprise a porous support and layer c) is free from porous supports. When only two of layers a), b) and c) comprise a porous support, the two layers optionally each comprise a separate support or the two layers comprise the same single support.
In a preferred embodiment at least third layer c) comprises a porous support.
In another embodiment, third layer c) is partly supported by a first porous support and partly unsupported. Preferably in this embodiment the membrane comprises a porous support which fully supports first layer a) or second layer b) and partly supports third layer c). The remaining layer (layer b) or layer a) as the case may be) is preferably free from porous supports or comprises a second porous support.
As examples of porous supports which may be included in the layers a), b) and/or c) there may be mentioned woven and non-woven synthetic fabrics and extruded films. Examples include wetlaid and drylaid non-woven material, spunbond and meltblown fabrics and nanofiber webs made from, e.g. polyethylene, polypropylene, polyacrylonitrile, polyvinyl chloride, polyphenylenesulfide, polyester, polyamide, polyaryletherketones such as polyether ether ketone and copolymers thereof. Porous supports may also be porous membranes, e.g. polysulfone, polyethersulfone, polyphenylenesulfone, polyphenylenesulfide, polyimide, polyethermide, polyamide, polyamideimide, polyacrylonitrile, polycarbonate, polyacrylate, cellulose acetate, poly(4-methyl 1 -pentene), polyinylidene fluoride, polytetrafluoroethylene, polyhexafluoropropylene and polychlorotrifluoroethylene membranes and derivatives thereof.
Preferably the porous support(s), when present, each independently have an average thickness of between 10 and 400pm, more preferably between 20 and 150pm and especially between 30 and 100pm.
Preferably the porous support(s), when present, have a porosity of between 30 and 95%. The porosity of a support may be determined by a porometer, e.g. a Porolux™ 1000 from IB-FT GmbH, Germany.
One or more of the porous supports may be treated to modify its surface energy, e.g. to values above 45 mN/m, preferably above 55mN/m. Suitable treatments include corona discharge treatment, plasma glow discharge treatment, flame treatment, ultraviolet light irradiation treatment, chemical treatment or the like, e.g. for the purpose of improving the wettability of and the adhesiveness to the porous support.
Commercially available porous supports are available from a number of sources, e.g. from Freudenberg Filtration Technologies (Novatexx materials), Lydall Performance Materials, Celgard LLC, APorous Inc., SWM (Conwed Plastics, DelStar Technologies), Teijin, Hirose, Mitsubishi Paper Mills Ltd and Sefar AG.
Preferably each porous support independently is a polymeric support. Preferred supports comprise a woven or non-woven synthetic fabric or an extruded film without covalently bound ionic groups.
Preferably the first layer a), the second layer b) and the third layer c) of the membrane each independently has an average thickness of between 4pm and 200pm, more preferably of between 5pm and 150pm and especially between 5 and 80pm. Preferably the third layer c) has a thickness of at least 4pm, more preferably at least 10pm.
Preferably the membrane of the present invention has an average thickness of between 30pm and 600pm, more preferably of between 60pm and 450pm and especially between 90 and 300pm.
The bipolar membrane of the present invention is especially suitable for uses which require a high current density, e.g. higher than 200mA/cm2.
The first, second, third and fourth polymers are preferably each independently obtained by a process comprising curing a curable composition comprising a curable compound having an ionic group, e.g. an anionic group or a cationic group. Thus, the first polymer may be obtained from a first curable composition, the second polymer may be obtained from a second curable composition, the third polymer may be obtained from a third curable composition and the fourth polymer may be obtained from a fourth curable composition.
Depending on the pH of the composition, the ionic groups may be partially or wholly in salt form. The curable compound having an ionic group may be rendered curable by the presence of one or more ethylenically unsaturated groups. Thus the curable compound having an ionic group preferably comprises an ethylenically unsaturated group and a cationic group or an anionic group. Anionic groups have a charge opposite to cationic groups.
Preferred ethylenically unsaturated groups include vinyl groups and (meth)acrylic groups (e.g. CH2=CR4C(O)- groups), especially allyl groups, aromatic vinyl groups (e.g. styrenic groups), (meth)acrylate groups (e.g. CH2=CR4 C(O)O- groups) and (meth )acry lam ide groups (e.g. CH2=CR4C(O)NR4- groups), wherein each R4 independently is H or CH3.
Preferred anionic groups are acidic groups, for example a sulpho, carboxy and/or phosphate groups, especially sulpho groups. The preferred salts are lithium, ammonium, sodium and potassium salts and mixtures comprising two or more thereof.
Preferred cationic groups are quaternary ammonium groups.
Examples of curable compounds having an anionic group or a quaternary ammonium group are provided below.
The curable compositions which may be used to prepare the first, second third and fourth polymers preferably further comprise a crosslinking agent, e.g. curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group, in an amount of 1 to 88 wt% (or 1 to 70wt%). Examples of curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group are provided below.
The curable compositions which may be used to prepare the first, second third and fourth polymers preferably further comprise a radical initiator, e.g. 0 to 10 wt% of radical initiator. Examples of suitable radical initiators are provided below.
The curable compositions which may be used to prepare the first, second third and fourth polymers preferably further comprise a solvent, e.g. 0 to 55wt% or 20 to 98 wt% of solvent. Examples of suitable solvents are provided below.
Preferably the first polymer (and optionally the fourth polymer) is obtainable by a process comprising curing a first curable composition comprising:
(a1 ) 0 to 60 wt% of a curable compound having one ethylenically unsaturated group and an ionic group of charge opposite to the charge of the ionic group of the curable compound present in the third curable composition;
(b1) 1 to 88 wt% of a curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group (of charge opposite to the charge of the ionic group of the curable compound present in the third curable composition);
(c1 ) 0 to 10 wt% of radical initiator; and
(d 1 ) 0 to 55 wt% of solvent.
Preferably the second polymer is obtainable by a process comprising curing a second curable composition comprising:
(a2) 0 to 60 wt% of a curable compound having one ethylenically unsaturated group and an ionic group of the same charge as the charge of the ionic group of the curable compound present in the third curable composition;
(b2) 1 to 88 wt% of a curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group (of the same charge as the charge of the ionic group of the curable compound present in the third curable composition);
(c2) 0 to 10 wt% of radical initiator; and
(d2) 0 to 55 wt% of solvent.
As mentioned above, the third polymer is preferably obtained from a process comprising polymerisation-induced phase separation of the third polymer from a third curable composition used to prepare the third polymer. This process is particularly useful for providing the third polymer in a form which comprises a network of pores capable of receiving a fourth curable composition (which may be identical to the first curable composition or different to the first curable composition) for preparation of the fourth polymer within the network of pores (and optionally on the surface of the third polymer too, if desired, in order to provide the first layer a) in a very efficient manner). In this way one may prepare and then impregnate the network of pores present in the third polymer with a fourth curable composition suitable for forming the fourth polymer and cure the fourth curable composition within the network of pores of the third
polymer and optionally on the surface of the third polymer in order to simultaneously make layer a) at the same time as making third layer c).
Preferably the third polymer comprising ionic groups is obtainable by a process comprising curing a third curable composition comprising:
(a3) 0 to 60 wt% of a curable compound having one ethylenically unsaturated group and an ionic group;
(b3) 1 to 70 wt% of a curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group;
(c3) 0 to 10 wt% of radical initiator; and
(d3) 20 to 98 wt% of solvent.
Preferably the charge of the ionic group of components (a3/b3) is the same as the charge of the ionic group of components (a2/b2) and opposite to the charge of the ionic group of components (a1/b1).
Preferably the fourth polymer is obtainable by a process comprising curing a fourth curable composition which falls within the definition provided above for the first curable composition. The fourth curable composition may be the same as or different to the first curable composition. Preferably the fourth curable composition comprises a curable compound having one ethylenically unsaturated group and an ionic group of charge opposite to the charge of the ionic group of the curable compound present in the third curable composition. Thus, - if different from the first polymer - the fourth polymer is obtainable by a process comprising curing a fourth curable composition comprising:
(a4) 0 to 60 wt% of a curable compound having one ethylenically unsaturated group and an ionic group of charge opposite to the charge of the ionic group of the curable compound present in the third curable composition;
(b4) 1 to 88 wt% of a curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group (of charge opposite to the charge of the ionic group of the curable compound present in the third curable composition);
(c4) 0 to 10 wt% of radical initiator; and
(d4) 0 to 55 wt% of solvent.
The amount of each of component (a1), (a2) and (a4) independently is preferably 0 to 40wt%.
The amount of component (a3) is preferably 0 to 30wt%, especially 0 to 20wt%.
The amount of each of components (b1 ), (b2) and (b4) independently is preferably 5 to 80wt%, especially 10 to 70wt%.
The amount of component (b3) is preferably 9 to 65wt%, especially 14 to 59wt%, more especially 19 to 49wt%.
The curable compositions which may be used to make the first, second, third and fourth polymers preferably comprise a radical initiator (component (c1), (c2), (c3) and (c4)) when it is intended to cure the composition by UV, visible light or thermally. Alternative methods for curing include electron beam and gamma irradiation. Those methods do not require a radical initiator. Thus the amount of component (c1), (c2), (c3) and (c4) present in the relevant
compositions is preferably 0 to 2wt%, more preferably (for curing by UV, visible light or thermally) 0.001 to 2wt%, especially 0.005 to 0.9wt%.
The amount of component (d1), (d2) and (d4) present in the relevant compositions is preferably 20 to 45wt%.
The amount of component (d3) is preferably 30 to 90wt%, especially 40 to 85wt%, more especially 49 to 78wt%.
Preferably the solvent(s) used as component (d1 ), (d2), (d3) and (d4) are inert, i.e. they do not react with any of the other components of the curable composition.
Component (d3) is preferably a single solvent. Preferably component (d3) is water.
Component (d3) optionally comprises two or more inert solvents, at least one of which is a solvent for the other components of the curable composition and at least one of which is a non-solvent for the third polymer formed from curing the composition, e.g. by phase separation, thereby forming the third polymer comprising a network of pores capable of receiving the fourth curable composition.
Examples of inert solvents which may be present in the curable compositions include water, alcohol-based solvents, ether-based solvents, amide-based solvents, ketone-based solvents, sulfoxide-based solvents, sulfone-based solvents, nitrile-based solvents and organic phosphorus-based solvents. Examples of alcohol-based solvents which may be used as or in component (d3) (especially in combination with water) include methanol, ethanol, isopropanol, n-propanol, n-butanol, ethylene glycol, propylene glycol, diethylene glycol, dipropylene glycol and mixtures comprising two or more thereof.
In addition, preferred inert, organic solvents which may be used in component (d1 ), (d2), (d3) and (d4) include dimethyl sulfoxide, dimethyl imidazolidinone, sulfolane, N-methyl pyrrolidone, dimethyl formamide, acetonitrile, acetone, 1,4-dioxane, 1,3-dioxolane, tetramethyl urea, hexamethyl phosphoramide, hexamethyl phosphorotriamide, pyridine, propionitrile, butanone, cyclohexanone, tetrahydrofuran, tetrahydropyran, 2-methyltetrahydrofuran, ethylene glycol diacetate, cyclopentylmethylether, methylethylketone, ethyl acetate, y- butyrolactone and mixtures comprising two or more thereof. Dimethyl sulfoxide, N-methyl pyrrolidone, dimethyl formamide, dimethyl imidazolidinone, sulfolane, acetone, cyclopentylmethylether, methylethylketone, acetonitrile, tetrahydrofuran, 2- methyltetrahydrofuran and mixtures comprising two or more thereof are preferable.
In one embodiment component (d3) comprises at least one of the solvents from list (i) below and at least one of the solvents from list (ii) below wherein the at least two solvents are different: list (i): iso-propanol, methanol, ethanol, acetone, tetramethyl urea, hexamethyl phosphoramide, hexamethyl phosphorotriamide, butanone, cyclohexanone, methylethylketone, tetrahydrofuran, tetrahydropyran, 2-methyltetrahydrofuran, cyclopentylmethylether, propionitrile, acetonitrile, 1 ,4-dioxane, 1 ,3-dioxolane, ethyl acetate, y- butyrolactone; and list (ii): water, glycerol, ethylene glycol, dimethyl sulfoxide, sulpholane, dimethyl imidazolidinone, sulfolane, N-methyl pyrrolidone, N,N-dimethyl formamide, N-methyl morpholine, acetonitrile, acetone, 1,4-dioxane, 1 ,3-dioxolane, tetramethyl urea, hexamethyl
phosphoramide, hexamethyl phosphorotriamide, pyridine, propionitrile, butanone, cyclohexanone, tetrahydrofuran, tetrahydropyran, 2-methyltetrahydrofuran, ethylene glycol diacetate, cyclopentyl methylether, methylethyl ketone, ethyl acetate and y-butyrolactone.
The choice of solvents depends on the other components of the composition.
In one embodiment component (d1 ), (d2), (d3) and (d4) comprises water and one or more other solvents from list (i).
Preferably one of the first curable composition and the second curable composition comprises a curable compound having an ethylenically unsaturated group and an anionic group and the other comprises a curable compound having an ethylenically unsaturated group and a cationic group. Furthermore, preferably one of the third curable composition and the fourth curable composition comprises a curable compound having an ethylenically unsaturated group and an anionic group and the other comprises a curable compound having an ethylenically unsaturated group and a cationic group. Examples of curable compounds having an ethylenically unsaturated group and an anionic group or cationic group include the following compounds of Formula (A), (B), (CL), (SM), (MA), (MB-a), (C), (ACL-A), (ACL-B), (ACL-C), and/or (AM-B):
RA1 to RA3 each independently represent a hydrogen atom or an alkyl group; RB1 to RB7 each independently represent an alkyl group or an aryl group;
ZA1 to ZA3 each independently represent -O- or -NRa-, wherein Ra represents a hydrogen atom or an alkyl group;
LA1 to LA3 each independently represent an alkylene group, an arylene group or a divalent linking group of a combination thereof;
Rx represents an alkylene group, an alkenylene group, an alkynylene group, an arylene group, or a divalent linking group of a combination thereof; and
XA1 to XA3 each independently represent an organic or inorganic anion, preferably a halogen ion or an aliphatic or aromatic carboxylic acid ion.
Examples of compounds of Formula (A) or (B) include:
Synthesis methods can be found in e.g. US2015/0353721 , US2016/0367980 and US2014/0378561.
wherein in Formulae (CL) and (SM):
L1 represents an alkylene group or an alkenylene group;
Ra, Rb, Rc, and Rd each independently represent a linear or branched alkyl group or an aryl group,
Ra and Rb, and/or Rc and Rd may form a ring by being bonded to each other; R1, R2, and R3 each independently represent a linear or branched alkyl group or an aryl group,
R1 and R2, or R1, R2 and R3 may form an aliphatic heterocycle by being bonded to each other; n1 , n2 and n3 each independently represent an integer of 1 to 10; and Xi , X2 and X3 each independently represent an organic or inorganic anion.
RA1 represents a hydrogen atom or an alkyl group;
Z1 represents -O- or -NRa-, wherein Ra represents a hydrogen atom or an alkyl group;
M+ represents an organic or inorganic cation, preferably a hydrogen ion or an alkali metal ion;
R^ represents a hydrogen atom or an alkyl group, RA4 represents an organic group comprising a sulphonic acid group and having no ethylenically unsaturated group; and
Z2 represents -NRa-, wherein Ra represents a hydrogen atom or an alkyl group preferably a hydrogen atom. Examples of formula (MA) and (MB-a) include:
L1 represents an alkylene group; n represents an integer of 1 to 3, preferably 1 or 2; m represents an integer of 1 or 2;
L2 represents an n-valent linking group;
R1 represents a hydrogen atom or an alkyl group;
R2 represents -SOs I T or -SO3R3; in case of plural R2‘s, each R2 independently represents - SO3M+ or -SO3R3;
M+ represents a hydrogen ion, an inorganic ion, or an organic ion; and
R3 represents an alkyl group or an aryl group.
Examples of formula (C) include:
Synthesis methods can be found in EP3187516.
M-B) wherein in Formulas (ACL-A), (ACL-B), (ACL-C) and (AM-B), each of R and R' independently represents a hydrogen atom or an alkyl group; LL represents a single bond or a bivalent linking group; each of LL1, LL1', LL2, and LL2' independently represents a single bond or a bivalent linking group; and each of A and A' independently represents a sulfo group in free acid or salt form; and m represents 1 or 2. Examples of formula (ACL-A), (ACL-B), (ACL-C) and (AM-B) include:
The curable compositions may be cured by any suitable process, including thermal curing, photocuring, electron beam (EB) radiation, gamma radiation, and combinations of the foregoing. However the curable compositions are preferably cured by photocuring, e.g. by irradiating the curable compositions by ultraviolet of visible light and thereby causing the curable components present in the compositions to polymerise.
Examples of suitable thermal initiators which may be included in the curable compositions include 2,2’-azobis(2-methylpropionitrile) (AIBN), 4,4’-azobis(4-cyanovaleric acid), 2,2’-azobis(2,4-dimethyl valeronitrile), 2,2’-azobis(2-methylbutyronitrile), 1,T-
azobis(cyclohexane-1 -carbonitrile), 2,2’-azobis(4-methoxy-2,4-dimethyl valeronitrile), dimethyl 2,2’-azobis(2-methylpropionate), 2,2’-azobis[N-(2-propenyl)-2-methylpropionamide, 1-[(1- cyano-1-methylethyl)azo] formamide, 2,2'-Azobis(N-butyl-2-methylpropionamide), 2,2'- Azobis(N-cyclohexyl-2-methylpropionamide), 2,2'-Azobis(2-methylpropionamidine) dihydrochloride, 2,2'-Azobis[2-(2-imidazolin-2-yl)propane]dihydrochloride, 2,2'-Azobis[2-(2- imidazolin-2-yl)propane]disulfate dihydrate, 2,2'-Azobis[N-(2-carboxyethyl)-2- methylpropionamidine] hydrate, 2,2'-Azobis{2-[1 -(2-hydroxyethyl)-2-imidazolin-2-yl]propane} dihydrochloride, 2,2'-Azobis[2-(2-imidazolin-2-yl)propane], 2,2'-Azobis(1 -imino- 1-pyrrolidino- 2-ethylpropane) dihydrochloride, 2,2'-Azobis{2-methyl-N-[1 , 1 -bis(hydroxymethyl)-2- hydroxyethl]propionamide} and 2,2'-Azobis[2-methyl-N-(2-hydroxyethyl)propionamide],
Examples of suitable photoinitiators which may be included in the curable compositions include aromatic ketones, acylphosphine compounds, aromatic onium salt compounds, organic peroxides, thio compounds, hexaarylbiimidazole compounds, ketoxime ester compounds, borate compounds, azinium compounds, metallocene compounds, active ester compounds, compounds having a carbon halogen bond, and an alkyl amine compounds. Preferred examples of the aromatic ketones, the acylphosphine oxide compound, and the thiocompound include compounds having a benzophenone skeleton or a thioxanthone skeleton described in "RADIATION CURING IN POLYMER SCIENCE AND TECHNOLOGY", pp.77- 117 (1993). More preferred examples thereof include an alpha-thiobenzophenone compound described in JP1972-6416B (JP-S47-6416B), a benzoin ether compound described in JP1972- 3981 B (JP-S47-3981B), an alpha-substituted benzoin compound described in JP1972-22326B (JP-S47-22326B), a benzoin derivative described in JP1972-23664B (JP-S47-23664B), an aroylphosphonic acid ester described in JP1982-30704A (JP-S57-30704A), dialkoxybenzophenone described in JP1985-26483B (JP-S60-26483B), benzoin ethers described in JP1985-26403B (JP-S60-26403B) and JP1987-81345A (JPS62-81345A), alphaamino benzophenones described in JP1989-34242B (JP H01-34242B), U.S. Pat. No. 4,318,791A, and EP0284561A1 , p-di(dimethylaminobenzoyl)benzene described in JP1990- 211452A (JP-H02- 211452A), a thio-substituted aromatic ketone described in JP1986- 194062A (JPS61-194062A), an acylphosphine sulfide described in JP1990-9597B (JP-H02- 9597B), an acylphosphine described in JP1990-9596B (JP-H02-9596B), thioxanthones described in JP1988-61950B (JP-S63-61950B), and coumarins described in JP1984-42864B (JP-S59-42864B). In addition, the photoinitiators described in JP2008-105379A and JP2009- 114290A are also preferable. In addition, photoinitiators described in pp. 65 to 148 of "Ultraviolet Curing System" written by Kato Kiyomi (published by Research Center Co., Ltd., 1989) may be used.
Especially preferred photoinitiators include Norrish Type II photoinitiators having an absorption maximum at a wavelength longer than 380nm, when measured in one or more of the following solvents at a temperature of 23°C: water, ethanol and toluene. Examples include a xanthene, flavin, curcumin, porphyrin, anthraquinone, phenoxazine, camphorquinone, phenazine, acridine, phenothiazine, xanthone, thioxanthone, thioxanthene, acridone, flavone, coumarin, fluorenone, quinoline, quinolone, naphtaquinone, quinolinone, arylmethane, azo,
benzophenone, carotenoid, cyanine, phtalocyanine, dipyrrin, squarine, stilbene, styryl, triazine or anthocyanin-derived photoinitiator.
The curable compositions may be applied continuously to moving supports, preferably by means of a manufacturing unit comprising curable composition application stations, one or more curing stations comprising irradiation source(s) for curing the compositions, a membrane collecting station and a means for moving the supports from the curable composition application stations to the curing station(s) and to the membrane collecting station.
The curable composition application stations may be located at an upstream position relative to the curing station(s) and the curing station(s) is/are located at an upstream position relative to the membrane collecting station.
Examples of application techniques include slot die coating, slide coating, air knife coating, roller coating, screen- printing, and dipping. Depending on the used technique and the desired end specifications, it might be necessary to remove excess coating from the substrate by, for example, roll-to-roll squeeze, roll-to-blade or blade-to-roll squeeze, blade-to-blade squeeze or removal using coating bars. Curing by ultraviolet of visible light can occur at wavelengths between 100 nm and 800 nm using doses between 40 and 20000 mJ/cm2. Thermal curing preferably takes place in the range between 20°C and 100°C for 0 to 20 h.
In some cases additional drying might be needed for which temperatures between 40°C and 200°C could be employed.
According to a second aspect of the present invention there is provided a process for preparing a bipolar membrane having a CPE of 725 Ohrrr1.sn or lower (when measured at a current density of 25 mA/cm2) comprising the following steps:
(i) providing a second, third and fourth curable composition and optionally a first curable composition, each such composition comprising a curable compound having an ionic group, wherein: a), the ionic group of the curable compound present in the second curable composition has the same charge as the ionic group of the curable compound present in the third curable composition; b). the ionic group of the curable compound present in the fourth curable composition has a charge opposite to the charge of the ionic group of the curable compound present in the third curable composition; and c). when the first curable composition is provided, the ionic group of the curable compound present in the first curable composition has a charge opposite to the charge of the ionic group of the curable compound present in the third curable composition;
(ii) impregnating a porous support with the third curable composition;
(iii) curing the third curable composition present within the porous support by a process comprising phase separation of a third polymer from the third curable composition, wherein the third polymer comprises ionic groups and a network of pores, thereby providing a base layer comprising the porous support and the third polymer, wherein the base layer comprises a first side and a second side opposite to the first side;
(iv) contacting the first side of the base layer with the fourth curable composition such that at least a part of the fourth curable composition enters into at least a part of the pores of the
third polymer and optionally provides a layer of the fourth curable composition on the first side of the base layer;
(v) contacting the second side of the base layer with the second curable composition such that the second curable composition enters into any remaining pores of the third polymer and provides a layer of the second curable composition on the second side of the base layer;
(vi) if contacting the first side of the base layer with the fourth curable composition does not provide a layer of the fourth curable composition on the first side of the base layer, contacting the first side of the base layer with the first curable composition such that a layer of the first curable composition is provided on the first side of the base layer; and
(vii) curing the layers of curable composition present on each side of the base layer and present within the pores of the third polymer in any order or simultaneously to form: a first layer a) comprising a first polymer or a fourth polymer, in each case having ionic groups of charge opposite to the charge of the ionic groups of the third polymer, a second layer b) comprising a second polymer having ionic groups of the same charge as the charge of the ionic groups of the third polymer, and a third layer c) comprising a co-continuous polymeric network of (i) the third polymer having ionic groups; and (ii) the fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer and being present within the network of pores of the third polymer; wherein third layer c) is interposed between first layer a) and second layer b).
In one embodiment of the process, in step (i) the first curable composition is not provided and in step (vi) contacting the first side of the base layer with the fourth curable composition provides a layer of the fourth curable composition on the first side of the base layer (thus it is not necessary to contact the first side of the base layer with a first curable composition such that a layer of the first curable composition is provided on the first side of the base layer because the fourth curable composition provides the first layer a) in addition to the fourth polymer present in third layer c)).
In another embodiment in step (iv) a layer of the fourth curable composition is provided on the first side of the base layer and in step (vi) this layer is contacted with the first curable composition such that a layer of the first curable composition is provided on the layer of fourth curable composition present on the first side of the base layer, e.g. if the layer of fourth curable composition is very thin. The other steps are as described above.
The process of the second aspect of the present invention preferably provides a membrane according to the first aspect of the present invention.
In another preferred embodiment one of the first layer a) and the second layer b) comprises a porous support. This may be achieved by including a porous support in the first curable composition or second curable composition prior to curing during the above process.
In a preferred embodiment the first curable composition and the fourth curable composition each comprise a curable compound having an anionic group and both the second curable composition and the third curable composition comprise a curable compound having a cationic group.
In yet another preferred embodiment, step (ii) of the process further comprises placing the porous support impregnated with the third curable composition between transparent foils to give a sandwich of the impregnated porous support and two foils and then squeezing the sandwich, e.g. between rollers or blades, to remove any excess of third curable composition. After curing step (iii) the transparent foils may be removed before performing step (iv). In a further preferred embodiment curing of the third curable composition in step (iii) is performed under an inert atmosphere, e.g. under nitrogen, carbon dioxide or argon gas.
According to a third aspect of the present invention there is provided use of (a method for using) the bipolar membranes according to the first aspect of the present invention for use in various applications, including recovery and production of organic and inorganic acids and bases (e.g. ammonia, ethanolamine, lithium hydroxide, gluconic acid, formic acid, amino acids, sulphuric acid), production of oligosaccharides and proteins, and capture of CO2 and SO2 from flue gases. They have good durability in acidic and basic media, low swelling, and may be produced cheaply, quickly and efficiently.
According to a fourth aspect of the present invention there is provided a bipolar electrodialysis device comprising one or more bipolar membranes according to the first aspect of the present invention.
The invention will now be illustrated by the following, non-limiting examples in which all parts and percentages are by weight unless specified otherwise.
Synthesis of XL-A1 is described in EP2979748 as Synthesis Example 2 on page 21. PP means polypropylene and PE means polyethylene.
Preparation of the bipolar membranes
Example Ex1 (BPM1
First, second and third curable compositions were prepared by mixing the components indicated in Table 2. In this Example the first curable composition was also used as fourth curable composition.
A 100 pm thick layer of the third curable composition was applied to a transparent PET foil sheet using a Meyer bar. A porous support (FO2223-10C) was applied to the layer of the third curable composition, thereby becoming impregnated with the third curable composition. A second transparent PET foil sheet was applied to the impregnated porous support to provide a sandwich of the impregnated porous support between the two transparent foils. Gently all air was squeezed out of the porous support using a roller.
The sandwich of the impregnated porous support between the two transparent foils was irradiated using a Light Hammer LH10 from Fusion UV Systems fitted with a D-bulb working at 60% intensity at a speed of 5 m/min in order to cure the third curable composition present in the porous support. After curing, the transparent PET foils were removed and the
cured product was allowed to dry in the air at room temperature to give a base layer (i.e. a porous support comprising a third polymer comprising ionic groups and a network of pores) having a first side and a second side.
The first curable composition was applied to a transparent PET foil using a 80 pm Meyer bar. Then the base layer prepared as described above, was placed on top of the layer of first curable composition with the first side of the base layer contacting the first curable composition whereupon a part of the first composition (which in this case doubles-up as fourth composition) entered into the pores of the third polymer. This gave a base layer impregnated with the first curable composition and provided a layer of the first curable composition on the first side of the base layer.
The base layer impregnated with the first curable composition and having a layer of the first composition on its first side was irradiated on the second side of the base layer (i.e. the side without the first curable composition) using a Light Hammer LH10 from Fusion UV Systems fitted with a D-bulb working at 50% intensity at a speed of 5 m/min. The resulting cured film was a laminate of layer a) and layer c) in which the pores of the third polymer were filled with cured first curable composition.
A 100 pm layer of the second curable composition was applied to the second side of the laminate of layer a) and layer c) which was free from layer a) using a Meyer bar and a second porous support (FO2223-10C) was applied to the layer of the second curable composition. After 5 seconds excess second curable composition was removed using a 4 pm Meyer bar.
The resulting product was irradiated on both sides using a Light Hammer LH10 from Fusion UV Systems fitted with a D-bulb working at 50% intensity at a speed of 5 m/min in order to cure the second curable composition. Finally the PET foil was removed to give a bipolar, composite membrane according to the first aspect of the present invention comprising the first layer a), the second layer b) and the third layer c) interposed between the first layer a) and the second layer b).
Comparative Example CEx1 (BPM2)
Comparative Example BPM2 was prepared using the same method as used for Example 1 (BPM 1) except that a catalyst was applied as described below.
Prior to contacting the base layer with the layer of first curable composition the base layer of the comparative example (BPM2) was dipped in a catalyst solution comprising 1.35wt% of tin(ll)chloride (stannous chloride) in a slightly acidic aqueous solution, and allowed to dry at room temperature. Subsequently the base layer was dipped in a 0.12N NaOH solution to precipitate the catalyst and was allowed to dry at room temperature.
CPE Measurements
The Constant Phase Element (CPE) values of the bipolar membranes were determined by averaging three independent Electrochemical Impedance Spectroscopy (EIS) measurements.
The EIS measurement is based on Equations (1) and (2).
wherein
Z is the impedance of the equivalent circuit;
Rn represents the resistance from the solution and the membrane; WDR represents the resistance of the water dissociation reaction (WDR); j indicates an imaginary number; w is the frequency applied; n is a non-ideality factor illustrating the degree of non-ideality of the element;
CPE is the constant phase element;
Re(z) is the real part of the impedance; and Im (z) is the imaginary part of the impedance.
The EIS set-up consisted of a two-chamber flow cell and contained two Ag/AgCI reference electrodes and two electrodes (a working and a counter electrode) consisting of two Pt coated titanium discs of 16 cm2 and 1 mm in thickness. The reference electrodes were connected through a 3M KCI salt bridge using Haber-Luggin capillaries. The entire set-up was placed in a Faraday cage to increase the stability of the measurements and to reduce noise. An alternating current in the frequency range of 10kHz to 0,01Hz was applied using an impedance analyzer (Metrohm Autolab BV) as a galvanostat. The amplitude was set at 10% of the initial DC applied. Aqueous solutions of 1 M H2SO4 and 1 M KOH were used as the electrolytes, which were infused at 4 mL/s each. The temperature of the electrolytes was controlled at 25°C.An active surface area of 7 cm2 of each bipolar membrane sample was used for the measurement, with the CEL facing the cathode and the acidic stream and AEL facing the anode and the base stream.
The obtained Nyquist plots showed two semi-circles, of which the second semi-circle (at higher values of Re(z) (Q) is indicative of the water dissociation reaction resistance. These Nyquist plots were fitted against the equivalent circuit and plotted against their operating current densities. The software used was Nova 2.0 from Metrohm. The fit parameters were:
Circuit description [R(RQ)]
Maximum number of iterations 300
Maximum change in x2 (scaled) 0.001
Maximum iterations without improvement 50
Fitting style Impedance
The equivalent circuit used to represent the studied BPMs consisted of two main parts. At the high frequency domain, the voltage and current were typically in phase (0 = 0), which means that they had an ohmic relation and the impedance values could simply be represented by a resistor. This resistor (RQ) was attributed to the ohmic losses of the electrolytes and the monolayers of the BPM. At lower frequency values, a semicircle was ideally obtained in the first quadrant of the Nyquist plot, with its centre on the x-axis. This semicircle indicated the presence of a charge transfer reaction, which in the case of a BPM was the water dissociation reaction (WDR). This semicircle would ideally be represented by a capacitor in parallel with a resistor (RWDR). However, a bipolar membrane is an imperfect capacitor and hence it was preferred to use a CPE instead of a capacitor to represent the behaviour of the bipolar membranes. The equivalent circuit is depicted in Fig 1. CPE is a (non-intuitive) circuit element, which is accompanied by a non-ideality factor n that illustrates the degree of non-ideality of the element (n = 1 , when a CPE represents an ideal capacitor).
Current efficiency
Current Efficiency is defined as the ratio of the number of protons (mole) produced in a certain time period and the number of electric charges carried by current (Faraday) through the system in the same time period as shown in Equation (3):
Eq(3)
wherein An is the number of protons produced (determined through acid/base titration), / is the applied current, t is the time period of sample collection (which determines the volume to be titrated) and F is the Faraday’s constant. The setup used for this test resembled a ministack, where the BPM under test was sandwiched between an anion exchange membrane (AMX from Astom) and a cation exchange membrane (CMX from Astom) with 200pm spacers of 70% porosity (from Deukum) in between the membranes. A solution of 0.5 M NaCI was fed through the acid and base compartments of the ministack. The arrangement from anode to cathode was as follows: (CMX - spacer (base compartment) - BPM - spacer (acid compartment) - AMX). The electrode rinse solution used was also 0.5M NaCI. The BPM membrane active area was 37.84 cm2. The electrolyte flows were controlled by peristaltic pumps, where the volumetric flows of the acid and base compartments were set to 30 ml/min (6 cm/s), while that of the electrode rinse solution was set to 250 ml/min (50 cm/s). The test was conducted at ambient temperature (23°C) and the content of the acid compartment was collected and weighed and subsequently titrated to determine the number of protons produced. The average of four independent measurements was used to calculate current efficiency. The system was run in the specified conditions for 12 minutes prior to start sample collection.
Interfacial surface factor (S)
The interfacial surface factor (S) may be determined by counting the number of changes from an element characteristic for the third polymer to an element characteristic for the fourth polymer and vice versa, multiplied by the thickness of the third layer. The analysis may be obtained from a SEM-EDX mapping of a cross-section of the third layer. The
thickness of the third layer may be determined by cutting through the layer and measuring its thickness using scanning electron microscopy (SEM).
At current densities up to 16.85 mA/cm2, the CPE of BPM1 is lower than that of BPM2, demonstrating that the H+ and OH- ions are transported more efficiently away from the interface. At higher current densities (above about 20 mA/cm2), however, the membrane without catalyst, BPM2, has a lower CPE, indicating that at higher current densities the
membrane without catalyst has a higher ion transport efficiency than the membrane with catalyst.
Claims
1. A bipolar membrane which has a Constant Phase Element (CPE) of 725 Ohnr1.sn or lower when measured at a current density of 25 mA/cm2.
2. The bipolar membrane according to claim 1 which comprises: a) a first layer comprising a first polymer or a fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer; b) a second layer comprising a second polymer having ionic groups of the same charge as the charge of the ionic groups of the third polymer; and c) a third layer comprising a polymeric network of (i) a third polymer having ionic groups; and (ii) a fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer; wherein third layer c) is interposed between first layer a) and second layer b).
3. The bipolar membrane according to claim 2 wherein the polymeric network of the third polymer and the fourth polymer is co-continuous.
4. The bipolar membrane according to claim 2 or 3 wherein the polymeric network comprises the third polymer and the fourth polymer, wherein the third polymer provides a network of pores and the fourth polymer is present within that network of pores.
5. The bipolar membrane according to any one of claims 2 to 4 wherein the third polymer has been obtained by a process comprising polymerisation-induced phase separation of the third polymer from a composition used to prepare the third polymer.
6. The bipolar membrane according to claim 5 wherein the polymerisation-induced phase separation comprises photopolymerization-induced phase separation of the third polymer from a composition used to prepare the third polymer.
7. The bipolar membrane according to any one of the preceding claims comprising less than 0.20 mmol per m2 of catalysts which reduce the potential required for the bipolar membrane to achieve water splitting and/or which reduce the ionic resistance of the bipolar membrane.
8. The bipolar membrane according to claim 7 comprising less than 0.20 mmol per m2 of multivalent metal salts, multivalent metal oxides and organometallic compounds.
9. The bipolar membrane according to any one of the claims 2 to 8 wherein at least the third layer c) comprises a porous support.
10. The bipolar membrane according to any one of the claims 2 to 9 which comprises an interface at the junction of the third polymer and the fourth polymer which is uninterrupted, without any gaps and/or spaces between the third polymer and the fourth polymer.
11. The bipolar membrane according to any one of the claims 2 to 10 wherein the first, second, third and fourth polymers are each independently obtained by a process comprising curing a curable composition comprising a curable compound having an ionic group.
12. The bipolar membrane according to any one of the claims 2 to 11 wherein each of the first and the fourth polymer independently is obtainable by a process comprising curing a composition comprising:
(a1) 0 to 60 wt% of a curable compound having one ethylenically unsaturated group and an ionic group of charge opposite to the charge of the ionic group of the curable compound present in the third curable composition;
(b1) 1 to 88 wt% of a curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group of charge opposite to the charge of the ionic group of the curable compound present in the third curable composition;
(c1) 0 to 10 wt% of radical initiator; and
(d1) 0 to 55 wt% of solvent.
13. The bipolar membrane according to any one of the claims 2 to 12 wherein the second polymer is obtainable by a process comprising curing a composition comprising:
(a2) 0 to 60 wt% of a curable compound having one ethylenically unsaturated group and an ionic group of the same charge as the charge of the ionic group of the curable compound present in the third curable composition;
(b2) 1 to 88 wt% of a curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group of the same charge as the charge of the ionic group of the curable compound present in the third curable composition;
(c2) 0 to 10 wt% of radical initiator; and
(d2) 0 to 55 wt% of solvent.
14. The bipolar membrane according to any of the claims 2 to 13 wherein the third polymer is obtainable by a process comprising curing a composition comprising:
(a3) 0 to 60 wt% of curable compound having one ethylenically unsaturated group and an ionic group;
(b3) 1 to 70 wt% of a curable compound comprising at least two ethylenically unsaturated groups and optionally an ionic group;
(c3) 0 to 10 wt% of radical initiator; and
(d3) 20 to 98 wt% of solvent.
15. The bipolar membrane according to any one of the claims 2 to 14 wherein the first polymer comprises anionic groups and the second and the third polymer comprise cationic groups.
16. The bipolar membrane according to any of the preceding claims wherein the bipolar membrane has an interfacial surface factor (S) of at least 1.
17. A process for preparing a bipolar membrane having a CPE of 725 Ohnr1.sn or lower at a current density of 25 mA/cm2 comprising the following steps:
(i) providing a second, third and fourth curable composition and optionally a first curable composition, each such composition comprising a curable compound having an ionic group, wherein: a), the ionic group of the curable compound present in the second curable composition has the same charge as the ionic group of the curable compound present in the third curable composition; b). the ionic group of the curable compound present in the fourth curable composition has a charge opposite to the charge of the ionic group of the curable compound present in the third curable composition; and c). when the first curable composition is provided, the ionic group of the curable compound present in the first curable composition has a charge opposite to the charge of the ionic group of the curable compound present in the third curable composition;
(ii) impregnating a porous support with the third curable composition;
(iii) curing the third curable composition present within the porous support by a process comprising phase separation of a third polymer from the third curable composition, wherein the third polymer comprises ionic groups and a network of pores, thereby providing a base layer comprising the porous support and the third polymer, wherein the base layer comprises a first side and a second side opposite to the first side;
(iv) contacting the first side of the base layer with the fourth curable composition such that at least a part of the fourth curable composition enters into at least a part of the pores of the third polymer and optionally provides a layer of the fourth curable composition on the first side of the base layer;
(v) contacting the second side of the base layer with the second curable composition such that the second curable composition enters into any remaining pores of the third polymer and provides a layer of the second curable composition on the second side of the base layer;
(vi) if contacting the first side of the base layer with the fourth curable composition does not provide a layer of the fourth curable composition on the first side of the base layer, contacting the first side of the base layer with the first curable composition such that a layer of the first curable composition is provided on the first side of the base layer; and
(vii) curing the layers of curable composition present on each side of the base layer and present within the pores of the third polymer in any order or simultaneously to form: a first layer a) comprising a first polymer or a fourth polymer, in each case having ionic groups of charge opposite to the charge of the ionic groups of the third polymer,
a second layer b) comprising a second polymer having ionic groups of the same charge as the charge of the ionic groups of the third polymer, and a third layer c) comprising a polymeric network of (i) the third polymer having ionic groups; and (ii) the fourth polymer having ionic groups of charge opposite to the charge of the ionic groups of the third polymer; wherein third layer c) is interposed between first layer a) and second layer b).
18. The process according to claim 17 wherein the polymeric network of the third polymer and the fourth polymer is co-continuous.
19. The process according to claim 17 or 18 wherein the polymeric network comprises the third polymer and the fourth polymer, wherein the third polymer provides a network of pores and the fourth polymer is present within that network of pores.
20. The process according to any one of claims 17 to 19 wherein the membrane is as defined in any one of claims 1 to 16.
21. The process according to any one of claims 17 to 20 wherein the first curable composition and the fourth curable composition each comprise a curable compound having an anionic group and both the second curable composition and the third curable composition comprise a curable compound having a cationic group.
22. The process according to any one of claims 17 to 21 wherein step (ii) further comprises placing the porous support impregnated with the third composition between transparent foils to give a sandwich of the impregnated porous support and two foils and then squeezing the sandwich to remove any excess of third curable composition.
23. The process according to claim 22 wherein after curing step (iii) the transparent foils are removed before performing step (iv).
24. The process according to any one of claims 17 to 21 wherein curing of the third curable composition in step (iii) is performed under an inert atmosphere.
25. Use of the bipolar membrane according to any one of claims 1 to 16 for recovery and production of organic and inorganic acids and bases, production of oligosaccharides and proteins, and capture of CO2 and SO2 from flue gases.
26. A bipolar electrodialysis device comprising the bipolar membrane according to any one of claims 1 to 16.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2114000.9 | 2021-09-30 | ||
GBGB2114000.9A GB202114000D0 (en) | 2021-09-30 | 2021-09-30 | Membranes |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2023052506A1 true WO2023052506A1 (en) | 2023-04-06 |
Family
ID=78497836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2022/077120 WO2023052506A1 (en) | 2021-09-30 | 2022-09-29 | Membranes |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB202114000D0 (en) |
WO (1) | WO2023052506A1 (en) |
Citations (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS473981B1 (en) | 1968-06-11 | 1972-02-03 | ||
JPS476416B1 (en) | 1968-04-16 | 1972-02-23 | ||
JPS4722326B1 (en) | 1968-07-26 | 1972-06-22 | ||
JPS4723664B1 (en) | 1968-07-26 | 1972-07-01 | ||
US4253900A (en) | 1977-02-28 | 1981-03-03 | Allied Chemical Corporation | Method of making novel two component bipolar ion exchange membranes |
JPS5730704A (en) | 1980-06-24 | 1982-02-19 | Bayer Ag | Photopolymerizable mixture containing aroylphosphoric acid ester as photoinitiator |
US4318791A (en) | 1977-12-22 | 1982-03-09 | Ciba-Geigy Corporation | Use of aromatic-aliphatic ketones as photo sensitizers |
JPS5942864B2 (en) | 1979-04-13 | 1984-10-18 | 京セラミタ株式会社 | Method for preparing a projection manuscript and electrostatic photographic transfer film used therein |
EP0143582A2 (en) * | 1983-11-23 | 1985-06-05 | Chinese Petroleum Corporation | Bipolar membranes |
JPS6026483B2 (en) | 1972-07-28 | 1985-06-24 | チバ・ガイギ−・アクチエンゲゼルシヤフト | Sensitizer for polymerization-based photopolymerization reactions containing unsaturated compounds |
JPS6026403B2 (en) | 1977-05-17 | 1985-06-24 | メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Photosensitizer for photopolymerization of unsaturated compounds |
JPS61194062A (en) | 1985-02-21 | 1986-08-28 | メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Photopolymerization initiator using thio-substituted ketone compound |
JPS6281345A (en) | 1985-09-28 | 1987-04-14 | チバ―ガイギー アクチェンゲゼルシャフト | Copolymerizable photoinitiator |
US4673454A (en) | 1983-11-23 | 1987-06-16 | Chinese Petroleum Corp. | Process for preparing bipolar membranes |
EP0284561A2 (en) | 1987-03-26 | 1988-09-28 | Ciba-Geigy Ag | Alpha-aminoacetophenones as photo initiators |
JPS6361950B2 (en) | 1981-03-16 | 1988-11-30 | ||
JPH029596B2 (en) | 1980-05-27 | 1990-03-02 | Basf Ag | |
JPH029597B2 (en) | 1980-09-15 | 1990-03-02 | Basf Ag | |
JPH02211452A (en) | 1988-12-01 | 1990-08-22 | Polychrome Corp | Light initiator |
JP2008105379A (en) | 2006-09-29 | 2008-05-08 | Fujifilm Corp | Method and equipment for inkjet recording |
JP2009114290A (en) | 2007-11-05 | 2009-05-28 | Fujifilm Corp | Photocurable composition, inkjet recording ink composition, and method for inkjet-recording |
US20140378561A1 (en) | 2011-07-19 | 2014-12-25 | Fujifilm Manufacturing Europe Bv | Curable Compositions and Membranes |
CN104593819A (en) * | 2015-01-06 | 2015-05-06 | 山东天维膜技术有限公司 | Bipolar membrane and preparation method thereof |
US20150353721A1 (en) | 2013-02-15 | 2015-12-10 | Fujifilm Corporation | Polymer functional film and method for producing same |
US20150353696A1 (en) | 2013-03-07 | 2015-12-10 | Fujifilm Corporation | Functional polymer membrane, manufacturing method therefor, ion exchange membrane and proton conductive membrane equipped with functional polymer membrane, and ion exchange device |
US20160001238A1 (en) | 2013-03-26 | 2016-01-07 | Fujifilm Corporation | Polymer functional film and method for producing same |
WO2016113518A1 (en) * | 2015-01-16 | 2016-07-21 | Fujifilm Manufacturing Europe Bv | Curable compositions and membranes |
US20160362526A1 (en) | 2014-02-28 | 2016-12-15 | Fujifilm Corporation | Ion exchange membrane and method for manufacturing the same |
US20160367980A1 (en) | 2014-03-07 | 2016-12-22 | Fujifilm Corporation | Ion-exchange polymer and production method therefor, electrolyte membrane and production method therefor, and composition for producing ion-exchange polymer |
US20160369017A1 (en) | 2014-03-12 | 2016-12-22 | Fujifilm Corporation | Curable composition, polymer functional cured product, water-soluble acrylamide compound, and method for manufacturing same |
EP3184558A1 (en) | 2014-08-19 | 2017-06-28 | Fujifilm Corporation | Composition for forming polymeric membrane, process for producing same, polymeric membrane, separation membrane module, and ion exchange device |
EP3187516A1 (en) | 2014-08-28 | 2017-07-05 | Fujifilm Corporation | Curable composition, cured product of functional polymer, stack or device provided with functional polymer film, amide compound and method for producing same |
WO2017205458A1 (en) | 2016-05-24 | 2017-11-30 | Vanderbilt University | Nanofiber-based bipolar membranes, fabricating methods and applications of same |
EP3604404A1 (en) | 2017-03-28 | 2020-02-05 | Coway Co., Ltd. | Bipolar ion exchange membrane using heterogeneous ion exchange membrane as support and production method therefor |
JP2020097648A (en) * | 2018-12-17 | 2020-06-25 | 株式会社アストム | Bipolar membrane |
-
2021
- 2021-09-30 GB GBGB2114000.9A patent/GB202114000D0/en not_active Ceased
-
2022
- 2022-09-29 WO PCT/EP2022/077120 patent/WO2023052506A1/en active Application Filing
Patent Citations (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS476416B1 (en) | 1968-04-16 | 1972-02-23 | ||
JPS473981B1 (en) | 1968-06-11 | 1972-02-03 | ||
JPS4722326B1 (en) | 1968-07-26 | 1972-06-22 | ||
JPS4723664B1 (en) | 1968-07-26 | 1972-07-01 | ||
JPS6026483B2 (en) | 1972-07-28 | 1985-06-24 | チバ・ガイギ−・アクチエンゲゼルシヤフト | Sensitizer for polymerization-based photopolymerization reactions containing unsaturated compounds |
US4253900A (en) | 1977-02-28 | 1981-03-03 | Allied Chemical Corporation | Method of making novel two component bipolar ion exchange membranes |
JPS6026403B2 (en) | 1977-05-17 | 1985-06-24 | メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Photosensitizer for photopolymerization of unsaturated compounds |
JPH0134242B2 (en) | 1977-12-22 | 1989-07-18 | Ciba Geigy | |
US4318791A (en) | 1977-12-22 | 1982-03-09 | Ciba-Geigy Corporation | Use of aromatic-aliphatic ketones as photo sensitizers |
JPS5942864B2 (en) | 1979-04-13 | 1984-10-18 | 京セラミタ株式会社 | Method for preparing a projection manuscript and electrostatic photographic transfer film used therein |
JPH029596B2 (en) | 1980-05-27 | 1990-03-02 | Basf Ag | |
JPS5730704A (en) | 1980-06-24 | 1982-02-19 | Bayer Ag | Photopolymerizable mixture containing aroylphosphoric acid ester as photoinitiator |
JPH029597B2 (en) | 1980-09-15 | 1990-03-02 | Basf Ag | |
JPS6361950B2 (en) | 1981-03-16 | 1988-11-30 | ||
EP0143582A2 (en) * | 1983-11-23 | 1985-06-05 | Chinese Petroleum Corporation | Bipolar membranes |
US4673454A (en) | 1983-11-23 | 1987-06-16 | Chinese Petroleum Corp. | Process for preparing bipolar membranes |
JPS61194062A (en) | 1985-02-21 | 1986-08-28 | メルク・パテント・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | Photopolymerization initiator using thio-substituted ketone compound |
JPS6281345A (en) | 1985-09-28 | 1987-04-14 | チバ―ガイギー アクチェンゲゼルシャフト | Copolymerizable photoinitiator |
EP0284561A2 (en) | 1987-03-26 | 1988-09-28 | Ciba-Geigy Ag | Alpha-aminoacetophenones as photo initiators |
JPH02211452A (en) | 1988-12-01 | 1990-08-22 | Polychrome Corp | Light initiator |
JP2008105379A (en) | 2006-09-29 | 2008-05-08 | Fujifilm Corp | Method and equipment for inkjet recording |
JP2009114290A (en) | 2007-11-05 | 2009-05-28 | Fujifilm Corp | Photocurable composition, inkjet recording ink composition, and method for inkjet-recording |
US20140378561A1 (en) | 2011-07-19 | 2014-12-25 | Fujifilm Manufacturing Europe Bv | Curable Compositions and Membranes |
US20150353721A1 (en) | 2013-02-15 | 2015-12-10 | Fujifilm Corporation | Polymer functional film and method for producing same |
US20150353696A1 (en) | 2013-03-07 | 2015-12-10 | Fujifilm Corporation | Functional polymer membrane, manufacturing method therefor, ion exchange membrane and proton conductive membrane equipped with functional polymer membrane, and ion exchange device |
US20160001238A1 (en) | 2013-03-26 | 2016-01-07 | Fujifilm Corporation | Polymer functional film and method for producing same |
EP2979748A1 (en) | 2013-03-26 | 2016-02-03 | Fujifilm Corporation | Polymer functional film and method for producing same |
US20160362526A1 (en) | 2014-02-28 | 2016-12-15 | Fujifilm Corporation | Ion exchange membrane and method for manufacturing the same |
US20160367980A1 (en) | 2014-03-07 | 2016-12-22 | Fujifilm Corporation | Ion-exchange polymer and production method therefor, electrolyte membrane and production method therefor, and composition for producing ion-exchange polymer |
US20160369017A1 (en) | 2014-03-12 | 2016-12-22 | Fujifilm Corporation | Curable composition, polymer functional cured product, water-soluble acrylamide compound, and method for manufacturing same |
EP3184558A1 (en) | 2014-08-19 | 2017-06-28 | Fujifilm Corporation | Composition for forming polymeric membrane, process for producing same, polymeric membrane, separation membrane module, and ion exchange device |
EP3187516A1 (en) | 2014-08-28 | 2017-07-05 | Fujifilm Corporation | Curable composition, cured product of functional polymer, stack or device provided with functional polymer film, amide compound and method for producing same |
CN104593819A (en) * | 2015-01-06 | 2015-05-06 | 山东天维膜技术有限公司 | Bipolar membrane and preparation method thereof |
WO2016113518A1 (en) * | 2015-01-16 | 2016-07-21 | Fujifilm Manufacturing Europe Bv | Curable compositions and membranes |
WO2017205458A1 (en) | 2016-05-24 | 2017-11-30 | Vanderbilt University | Nanofiber-based bipolar membranes, fabricating methods and applications of same |
EP3604404A1 (en) | 2017-03-28 | 2020-02-05 | Coway Co., Ltd. | Bipolar ion exchange membrane using heterogeneous ion exchange membrane as support and production method therefor |
JP2020097648A (en) * | 2018-12-17 | 2020-06-25 | 株式会社アストム | Bipolar membrane |
Non-Patent Citations (6)
Title |
---|
CHEN YINGYING ET AL: "High-Performance Bipolar Membrane Development for Improved Water Dissociation", ACS APPLIED POLYMER MATERIALS, vol. 2, no. 11, 19 August 2020 (2020-08-19), pages 4559 - 4569, XP055928389, ISSN: 2637-6105, DOI: 10.1021/acsapm.0c00653 * |
DATABASE WPI Week 201551, 6 May 2015 Derwent World Patents Index; AN 2015-41486E, XP002806730 * |
DATABASE WPI Week 2020005, 25 June 2020 Derwent World Patents Index; AN 2020-573304, XP002806731 * |
KATO KIYOMI: "Ultraviolet Curing System", 1989, RESEARCH CENTER CO., LTD. |
MCCLURE, ECS TRANSACTIONS, vol. 69, no. 18, 2015, pages 35 - 44 |
RADIATION CURING IN POLYMER SCIENCE AND TECHNOLOGY, 1993, pages 77 - 117 |
Also Published As
Publication number | Publication date |
---|---|
GB202114000D0 (en) | 2021-11-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2734292B1 (en) | Ion exchange membranes | |
AU2012285539B2 (en) | Curable compositions and membranes | |
US20120006685A1 (en) | Process for Preparing Composite Membranes | |
KR101586769B1 (en) | Manufacturing Method of Thin Ion Exchange Membrane Using High Molecular Support | |
EP4314092A1 (en) | Cationically charged membranes | |
US20230311071A1 (en) | Composite Membrane | |
JP2023544307A (en) | Compounds, compositions, and polymer films | |
JP2023544993A (en) | Compositions and polymer films | |
WO2023186622A1 (en) | Bipolar membranes | |
WO2023052506A1 (en) | Membranes | |
WO2023151941A1 (en) | Membranes | |
EP4314123A1 (en) | Polymer films | |
JP2016137434A (en) | Polymer functional film, and production method, laminate, and device thereof | |
US20230347333A1 (en) | Membranes | |
WO2023052226A1 (en) | Membranes | |
WO2023052225A1 (en) | Membranes | |
WO2024132502A1 (en) | Membranes | |
WO2024068595A1 (en) | Membranes | |
WO2024068598A1 (en) | Membranes | |
WO2024132498A1 (en) | Membranes | |
WO2023186619A1 (en) | Bipolar membranes | |
WO2024068601A1 (en) | Membranes |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 22802515 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 22802515 Country of ref document: EP Kind code of ref document: A1 |